methotrexate has been researched along with Lymph Node Metastasis in 625 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 237 (37.92) | 18.7374 |
1990's | 191 (30.56) | 18.2507 |
2000's | 149 (23.84) | 29.6817 |
2010's | 46 (7.36) | 24.3611 |
2020's | 2 (0.32) | 2.80 |
Authors | Studies |
---|---|
Byrski, T; Kaczmarek, K; Lemiński, A; Słojewski, M | 1 |
Bogachev, SS; Kabakov, AV; Kazakov, OV; Konenkov, VI; Lykov, AP; Poveshchenko, AF; Raiter, TV; Strunkin, DN | 1 |
Chen, CS; Cheng, CL; Chiu, KY; Ho, HC; Hung, SC; Li, JR; Ou, YC; Wang, SS; Yang, CK | 1 |
Almquist, H; Bläckberg, M; Cwikiel, M; Gudjonsson, S; Kollberg, P; Liedberg, F; Lyttkens, K; Patschan, O | 1 |
Ishchenko, IY; Kabakov, AV; Kazakov, OV; Konenkov, VI; Lykov, AP; Michurina, SV; Poveshchenko, AF; Raiter, TV; Strunkin, DN | 1 |
Ivanov, VV; Klimov, IA; Kondakova, IV; Korshunov, DA | 1 |
Han, W; Im, SA; Moon, HG; Moon, WK; Noh, DY; Park, IA; Park, SJ; Shin, HC | 1 |
Izumi, K; Kadono, Y; Kitagawa, Y; Konaka, H; Miwa, S; Mizokami, A; Namiki, M | 1 |
Domínguez, ME; Fasce, HM; Iturbe, J; Langui, M; Leone, BA; Leone, J; Leone, JP; Machiavelli, MR; Ortiz, E; Pérez, JE; Romero Acuña, L; Romero, AO; Vallejo, CT; Zwenger, AO | 1 |
Kaczmarczyk, J; Kaczmarek, K; Kubaszewski, Ł; Nowakowski, A; Sulewski, A; Wiącek, MP | 1 |
Chang, HK; Chen, SC; Hsueh, S; Lin, YC; Lo, YF; Wu, CE | 1 |
Fushimi, K; Takami, M; Tanabe, N | 1 |
Li, S; Liang, X; Liu, J; Wei, L | 1 |
Bian, J; Han, Z; Li, S; Pei, F; Wang, H; Wang, Z; Xu, J; Xu, Z; Yang, M; Zou, B | 1 |
Chen, CH; Chiang, PH; Shen, YC | 1 |
Abbasi, MM; Hamishehkar, H; Jahanban- Esfahlan, R; Monfaredan, A; Seidi, K | 1 |
Chang, WH; Chen, PC; Chen, WM; Chiou, HJ; Hsu, HE; Hung, GY; Wu, HT; Yen, CC; Yen, HJ | 1 |
Aurilio, G; Bagnardi, V; Curigliano, G; Goldhirsch, A; Graffeo, R; Iera, M; Locatelli, M; Martella, S; Munzone, E; Nolè, F; Petit, JY; Rey, P; Rotmensz, N | 1 |
Xu, M; Xu, S; Yu, X | 1 |
Cote, RJ; Godoy, G; Groshen, S; Kryvenko, ON; Lerner, SP; Mata, DA; Skinner, DG; Stadler, WM; Stein, JP; von Rundstedt, FC | 1 |
Abdessamad, C; Elmortaji, K; Fethi, M; Halfya, A; Mohamed, E; Rafik, A; Redouane, R | 1 |
Baretton, GB; Froehner, M; Hakenberg, OW; Heberling, U; Hübler, M; Koch, R; Novotny, V; Oehlschlaeger, S; Wirth, MP | 1 |
Chen, YY; Chiang, PH; Hsieh, MC; Huang, CH; Rau, KM; Su, YL | 1 |
Broggini, M; Cavalli, IJ; Chilà, R; Damia, G; de Lima, RS; de Oliveira, SF; Ganzinelli, M; Generali, D; Maciel, ME; Ribeiro, EM; Serino, L; Urban, Cde A | 1 |
Allory, Y; Bastuji-Garin, S; Beuzeboc, P; Chevreau, C; Culine, S; Houédé, N; Le Thuaut, A; Loriot, Y; Pouessel, D; Sevin, E; Taille, A; Vordos, D | 1 |
Bais, EM; de Vries, RR; Horenblas, S; Meinhardt, W; Nieuwenhuijzen, JA | 1 |
Castiglione-Gertsch, M; Coates, AS; Collins, J; Crivellari, D; Fey, MF; Forbes, JF; Gelber, RD; Gelber, S; Goldhirsch, A; Holmberg, SB; Lindtner, J; Murray, E; Pagani, O; Price, KN; Simoncini, E; Thürlimann, B | 1 |
Haid, A; Konstantiniuk, P; Kugler, F; Pöstlberger, S; Reitsamer, R; Roka, S; Tausch, C | 1 |
Iwata, H; Kitaya, T; Kohno, N; Nakagami, K; Ohashi, Y; Sakamoto, G; Sano, M; Shimozuma, K; Sonoo, H; Takashima, S; Tokuda, Y; Tsuda, H; Watanabe, T; Yoshimoto, M | 1 |
Beraki, E; Kåresen, R; Naume, B; Park, D; Sauer, T; Synnestvedt, M | 1 |
Abe, R; Kimijima, I; Kimura, M; Koyama, H; Miura, S; Nomura, Y; Ohashi, Y; Takashima, S; Takatsuka, Y; Tashiro, H; Toi, M; Tominaga, T | 1 |
Asaga, T; Higaki, K; Inaji, H; Ito, T; Koh, J; Kohno, N; Komichi, H; Koyama, H; Kyono, S; Mitsuyama, S; Nishikawa, H; Ogita, M; Okamura, K; Osaki, A; Park, Y; Saito, T; Suzuki, T; Tanaka, F; Yamazaki, K | 1 |
Kawashima, A; Miyoshi, S; Nin, M; Nishimura, K; Ujike, T | 1 |
Conrad, AL; Go, RS | 1 |
Brünner, N; Foekens, JA; Look, MP; Meijer-van Gelder, ME; Schrohl, AS | 1 |
Ataseven, B; Conrad, B; Eiermann, W; Graf, E; Hilfrich, J; Kaufmann, M; Loibl, S; Massinger-Biebl, H; Schumacher, M; Vescia, S; von Minckwitz, G | 1 |
Bianchi, S; Biti, GP; Borghesi, S; Cataliotti, L; De Luca Cardillo, C; Greto, D; Livi, L; Mangoni, M; Paiar, F; Saieva, C; Scotti, V | 1 |
Cao, WF; Cao, XC; Hao, XS; Ning, LS; Niu, Y; Song, YQ; Zhang, B; Zhao, HM | 1 |
Abdelaziz, NN; Abdelhafeez, ZM; Essa, AE; Gado, NM; Kamel, TH; Salem, DA | 1 |
Fujisawa, M; Miyake, H; Muramaki, M; Takenaka, A; Terakawa, T | 1 |
Faradmal, J; Gohari, MR; Hajizadeh, E; Kazemnejad, A; Khodabakhshi, R | 1 |
Xu, BH; Zhang, P | 1 |
Amadori, D; Amaducci, L; Baldini, E; Biglia, N; Boccardo, F; Bonginelli, P; Brandi, M; De Lena, M; Faedi, M; Gianni, L; Maltoni, R; Paradiso, A; Ponzone, R; Rocca, A; Scarpi, E; Schittulli, F; Serra, P; Silvestrini, R; Tienghi, A; Valerio, MR | 1 |
Balandra, A; Bergey, MR; Canter, DJ; Guzzo, TJ; Magerfleisch, L; Malkowicz, SB; Resnick, MJ; Tomaszewski, JE; Vaughn, DJ | 1 |
Fett, N; Liu, RH | 1 |
Aebi, S; Braun, D; Castiglione-Gertsch, M; Coates, AS; Crivellari, D; Gelber, RD; Goldhirsch, A; Gusterson, BA; Karlsson, P; Lindtner, J; Price, KN; Rabaglio, M; Regan, MM; Simoncini, E; Snyder, R; Sun, Z; Viale, G | 1 |
Baak, JP; Gilje, B; Janssen, EA; Nordgård, O; Smaaland, R; Søiland, H; Tjensvoll, K | 1 |
Buckman, R | 1 |
Bafaloukos, D; Batistatou, A; Bobos, M; Briasoulis, E; Christodoulou, C; Dafni, U; Dimopoulos, MA; Eleftheraki, AG; Fountzilas, G; Gogas, H; Kalofonos, HP; Karanikiotis, C; Karina, M; Kosmidis, P; Markopoulos, C; Papadimitriou, C; Papakostas, P; Pectasides, D; Samantas, E; Stathopoulos, GP; Timotheadou, E | 1 |
Malmström, PU; Nilsson, S; Rintala, E; Rosenblatt, R; Sherif, A; Ullén, A; Wahlqvist, R | 1 |
Aguirre-González, EH; Verduzco-Aguirre, HC; Verduzco-Rodríguez, L | 1 |
Bouchardy, C; Dehler, S; Ess, S; Frick, H; Joerger, M; Konzelmann, I; Savidan, A; Thürlimann, B | 1 |
Hayashi, T; Ishii, T; Itami, Y; Kobayashi, Y; Minami, T; Nagai, Y; Nozawa, M; Shimizu, N; Uemura, H; Yamamoto, Y; Yoshimura, K | 1 |
Danga, A; Hemmaway, CJ; Igbokwe, U; Radunovic, A | 1 |
Abotouk, N; Halim, A | 1 |
Li, F; Liu, X; Niu, Z; Wang, L; Wang, X; Wang, Y; Zhang, L | 1 |
Igarashi, M; Kawaai, Y; Kitamura, H; Masumori, N; Shindo, T; Tamakawa, M; Tanaka, T; Tsukamoto, T | 1 |
Megahed, M; Pfaff, S | 1 |
Andersson, M; Buyse, M; Crown, J; De Azambuja, E; Dell'orto, P; Di Leo, A; Francis, PA; Gelber, RD; Gutiérrez, J; Harvey, V; Jakesz, R; Larsimont, D; Margeli Vila, M; Nordenskjöld, B; Oakman, C; Piccart-Gebhart, M; Punzalan, L; Quinaux, E; Steinberg, I; Thürlimann, B; Viale, G | 1 |
Crown, JP; de Azambuja, E; Di Leo, A; Francis, P; Hitre, E; Loi, S; Michiels, S; Piccart, MJ; Piette, F; Quinaux, E; Rouas, G; Salgado, R; Sirtaine, N; Sotiriou, C; Van Eenoo, F; Viale, G | 1 |
Bella, M; Bisagni, G; Boni, C; Bruzzi, P; Camisa, R; Ceci, G; Cocconi, G; Di Blasio, B; Leonardi, F; Rondini, E; Savoldi, L | 1 |
Arcuri, MF; Corcione, L; Del Rio, P; Sivelli, R | 1 |
Benito, E; Escobedo, A; Gumà, A; Moreno, A; Riu, F; Serra, JM | 1 |
Borovik, R; Brenner, HJ; Brenner, J; Catane, R; Chaitchik, S; Farbstein, H; Inbar, MJ; Peretz, T; Rizel, S; Ron, IG; Shani, A; Wigler, N | 1 |
Gunduz, M; Haisa, M; Naomoto, Y; Shigemitsu, K; Shirakawa, Y; Tanaka, N | 1 |
Brundage, M; Chin, JL; Lukka, H; Markman, BR; Segal, R; Winquist, E | 1 |
Anderson, A; Cameron, DA; Crown, J; Evans, TR; Grieve, RJ; Jones, A; Kennedy, IC; Le Vay, JH; Leonard, RC; Mansi, J; Perren, TJ; Toy, E | 1 |
Blamey, R; Cuzick, J; de Haes, JC; de Matteis, A; Eiermann, W; Fogelman, I; Geberth, M; Jonat, W; Kaufmann, M; Lisboa, B; Namer, M; Palmer, M; Sauerbrei, W; Schumacher, M; Stewart, A; Szakolczai, I | 1 |
Athens, JW; Costanzi, JJ; Green, SJ; Lew, D; Martino, S; Osborne, CK; Rivkin, SE; Vaughn, CB | 1 |
Shimizu, C; Watanabe, T | 1 |
Holmberg, L; Malmström, PU; Mestad, O; Nilsson, J; Nilsson, S; Rintala, E; Sherif, A | 1 |
Knap, MM; Lundbeck, F; Overgaard, J | 1 |
Accettura, C; Bernard-Marty, C; Cardoso, F; Di Leo, A; Kleiber, K; Larsimont, D; Lobelle, JP; Mano, M; Munoz-Bermeo, R; Paesmans, M; Piccart, MJ; Richard, T | 1 |
Berry, DA; Bothun, S; Cirrincione, CT; Demakos, E; Falkson, G; Henderson, IC; Holland, JF; Norton, L; Robbins, A; Weiss, RB; Woolf, SH | 1 |
Colleoni, M; Goldhirsch, A | 1 |
Fridrik, M; Gnant, M; Haider, K; Hausmaninger, H; Jakesz, R; Kolb, R; Kubista, E; Mlineritsch, B; Ploner, F; Samonigg, H; Seifert, M; Steger, G; Steindorfer, P; Stierer, M; Tschurtschenthaler, G | 1 |
Emi, Y; Kakeji, Y; Kimura, Y; Maehara, Y; Sakurai, M; Takahashi, I; Yonemura, Y | 1 |
Albanell, J; Aranda, J; Campbell, J; Camps, C; Candel, MT; Carrato, A; Casado, A; Diaz-Rubio, E; Gonzalez, R; Lizon, J; Martin, M; Massuti, B; Munarriz, B; Sole-Calvo, A; Villar, A | 1 |
Blamey, R; Cuzick, J; de Haes, JC; Fogelman, I; Jonat, W; Kaufmann, M; Namer, M; Sauerbrei, W; Schumacher, M | 1 |
Baba, Y; Hayashi, S; Ishikawa, T; Kamimura, T; Nomura, K; Oota, H; Yoshida, T | 1 |
JACQUET, J | 1 |
ANDRE, P; DUFOUR, A | 1 |
ARIEL, IM; GALEY, D; RESNICK, MI | 1 |
DARBY, CP | 1 |
BAKER, RR; GAERTNER, RA | 1 |
Al-Mwalad, M; Albers, P; Becker, T; Brauers, A; Brkovic, D; Bub, P; Derigs, HG; Fassmann, C; Hamza, A; Hartlapp, J; Henss, H; Hertle, L; Jaeger, E; Jakse, G; Kälble, T; Kaldenbach, U; Knuth, A; Koser, M; Lehmann, J; Lippert, C; Loch, T; Melchior, H; Muschter, R; Otto, C; Piechota, HJ; Pomer, S; Potratz, C; Retz, M; Richter, AE; Roloff, J; Roth, S; Steiner, G; Stockamp, K; Stöckle, M; Tunn, U; Van Ahlen, H; Walz, P; Weinknecht, S; Weissbach, L; Winter, E; Wirth, M | 1 |
Kosnikov, AG; Maksimov, SIa; Semiglazov, VF; Semiglazov, VV | 1 |
de Haes, H; Jonat, W; Kaufmann, M; Olschewski, M; Sauerbrei, W; Schumacher, M | 1 |
Krege, S; Otto, T; Rübben, H; Suhr, J | 1 |
Akiyama, N; Arai, F; Funakoshi, K; Inayoshi, J; Kato, T; Motoyama, H; Tasaki, A | 1 |
Bonetti, M; Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Gelber, RD; Goldhirsch, A; Nasi, ML; O'Neill, A; Price, KN | 1 |
Beex, LV; De Mulder, PH; Grol, RP; Ottevanger, PB; van Lier, H | 1 |
Coebergh, JW; Ernst, MF; Poortmans, PM; Roukema, JA; Voogd, AC | 1 |
Aebersold, DM; Altermatt, HJ; Berclaz, G; Djonov, V; Greiner, RH; Gruber, G; Hlushchuk, R | 1 |
Calais, G | 1 |
Carrie, C; Claude, L; Petit, T | 1 |
Deguchi, T; Ehara, H; Ishihara, S; Masue, T; Mizutani, K; Seike, K; Sugawara, T; Takahashi, Y; Yokoi, S | 1 |
Arai, K; Ema, T; Iwasaki, Y; Katayanagi, S; Maeda, Y; Takahashi, K; Takahashi, T; Yamaguchi, T | 1 |
de Vries, EG; Otter, R; Schaapveld, M; van der Graaf, WT; Willemse, PH | 1 |
Barrett-Lee, P; Cameron, D; Coleman, R; Crown, J; Foster, E; Kennedy, I; Ledermann, J; Leonard, RC; Lind, M; Perren, T; Twelves, C; van Belle, S; Verrill, M; Wilson, C; Yellowlees, A | 1 |
Abe, R; Aoyama, H; Asaga, T; Awane, H; Danno, M; Ikeda, T; Kimura, M; Koyama, H; Mitsuyama, S; Nishi, T; Ogita, M; Sano, M; Takashima, S; Takatsuka, Y; Toi, M; Tominaga, T; Wada, T; Yoshida, M | 1 |
Abe, H; Endo, Y; Hanasawa, K; Kushima, R; Naitoh, H; Tani, T | 1 |
Anderson, S; Bryant, J; Deutsch, M; Jeong, JH; Mamounas, E; Taghian, A; Wolmark, N | 1 |
Komatsu, H; Matsuzaki, M; Morikawa, H; Nakanishi, S; Nakano, M | 1 |
Albain, KS | 1 |
Anderson, S; Fisher, B; Jeong, JH; Wolmark, N | 1 |
Coldman, AJ; Coppin, CM; Durand, R; Gelmon, K; Jackson, SM; Knowling, MA; Le, N; Manji, M; Olivotto, IA; Phillips, N; Ragaz, J; Spinelli, JJ; Weir, L; Wilson, KS | 1 |
Eren, E; Metindir, J; Ozdilekcan, C; Pak, I | 1 |
Adamo, V; Bianco, AR; Costanzo, R; D'Aprile, M; De Laurentiis, M; De Lena, M; De Placido, S; Farris, A; Ferraù, F; Lauria, R; Limite, G; Lorusso, V; Manzione, L; Pagliarulo, C; Palazzo, S; Palmeri, S; Paradiso, A; Petrella, G; Pistillucci, G; Sarobba, MG | 1 |
Radice, D; Redaelli, A | 1 |
Ohtake, T; Okayama, H; Sagara, H; Takenoshita, S; Watanabe, K; Yasuda, M | 1 |
Fu, JH; Huang, ZF; Lin, P; Long, H; Rong, TH; Tang, J; Wang, SY; Wang, X; Yang, MT; Zeng, CG | 1 |
Fukuda, H; Habuchi, T; Iinuma, M; Kato, T; Kumazawa, T; Minagawa, S; Mitsumori, K; Satoh, K; Satoh, S; Tadachi, K | 1 |
Mazeron, JJ | 1 |
Bex, A; Horenblas, S; Kerst, JM; Meinhardt, W; Nieuwenhuijzen, JA; Schornagel, JH; VAN Tinteren, H | 1 |
Matsuda, H; Mikami, Y; Nagao, J; Sakuma, N; Tsukuda, M; Yoshida, T | 1 |
Dillenschneider, E; Greiner, GF | 1 |
Hiramatsu, K; Mizukami, Y; Momiyama, M; Nagashima, T; Niimi, K; Suzuki, M | 1 |
Bonetti, M; Carbone, A; Castiglione-Gertsch, M; Coates, AS; Collins, J; Crivellari, D; Fey, MF; Gelber, RD; Goldhirsch, A; Golouh, R; Gruber, G; Holmberg, SB; Lindtner, J; Nasi, ML; Price, KN; Rudenstam, CM; Simoncini, E; Thürlimann, B | 1 |
Sanuki-Fujimoto, N | 1 |
Chang, HK; Chen, MF; Chen, SC; Hsueh, S; Hwang, TL; Lin, YC; Lo, YF; Tsai, CS | 1 |
Hamada, T; Ichimura, W; Minagawa, N; Mino, K; Naito, H; Orimo, T; Shibazaki, W; Shinohara, T | 1 |
Alagol, H; Atalay, C; Camlibel, M; Dinc, S; Gulcelik, MA; Kuru, B | 1 |
Franzaring, L; Lehmann, J; Stöckle, M; Thüroff, J; Wellek, S | 1 |
Blohmer, JU; Breitbach, GP; Budner, M; Elling, D; Kohls, A; Krocker, J; Kümmel, S; Lichtenegger, W; Morack, G | 1 |
Baltas, D; Filipowicz, I; Hoffmann, G; Kolotas, C; Kontova, M; Kuner, RP; Kurek, R; Martin, T; Pollow, B; Roddiger, SJ; Rogge, B; Zamboglou, N | 1 |
Chen, CM; Cheng, SH; Clarke, JL; Horng, CF; Huang, AT; Jian, JJ; Liu, MC; Prosnitz, LR; Tsai, SY; Tsou, MH; West, M | 1 |
Ito, Y; Tokudome, N | 1 |
Blohmer, JU; Breitbach, GP; Budner, M; Elling, D; Kohls, A; Krocker, J; Kümmel, S; Morack, G | 1 |
Panasci, LC | 1 |
Baehner, FL; Baker, J; Bryant, J; Costantino, JP; Cronin, M; Geyer, CE; Kim, C; Kim, W; Paik, S; Shak, S; Tang, G; Watson, D; Wickerham, DL; Wolmark, N | 1 |
Battelli, N; Braconi, C; Cascinu, S; Cobelli, S; Dinota, A; Giacomini, G; Giorgi, F; Manzione, L; Massacesi, C; Morale, D; Pilone, A; Scanni, A; Sturba, F; Tummarello, D | 1 |
Balduzzi, A; Cardillo, A; Colleoni, M; Ghisini, R; Goldhirsch, A; Orlando, L; Peruzzotti, G; Pietri, E; Rocca, A; Torrisi, R | 1 |
Gordon, NH; Lasheen, W; Meinert, J; Silverman, P; Siminoff, LA | 1 |
Anderson, WF; Berman, AW; Lippman, ME; Steinberg, SM; Swain, SM; Vatas, U; Walshe, JM | 1 |
Fujioka, H; Hatano, K; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tsujimoto, Y | 1 |
Carrato Mena, A; Guillén Ponce, C; Maciá Escalante, S; Martínez Banaclocha, N; Pons Sanz, V; Rodríguez Lescure, A | 1 |
Fernö, M; Johnsson, A; Malmström, J; Marko-Varga, G; Niméus, E | 1 |
Higuchi, K; Kobayashi, N; Koizumi, W; Mitomi, H; Nakatani, K; Nakayama, N; Nishimura, K; Saigenji, K; Sasaki, T; Shimoda, T; Tanabe, S | 1 |
Arai, Y; Hatano, K; Inoue, H; Kawashima, A; Miyagawa, Y; Miyake, O; Nishimura, K; Okuyama, A; Takaha, N | 1 |
Boudawara, T; Daoud, J; Frikha, M; Kallel, F; Khanfir, A; Meziou, M; Mnif, J; Trabelsi, K | 1 |
Maruyama, M; Maruyama, S; Nagahama, T | 1 |
Nielsen, HM; Overgaard, J; Overgaard, M | 1 |
Buchholz, TA; Olivotto, IA; Ragaz, J; Thames, HD; Truong, PT; Woodward, WA | 1 |
Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Gelber, RD; Gelber, S; Goldhirsch, A; Pagani, O; Price, KN; Simoncini, E | 1 |
Cymek, S; Kanczuga-Koda, L; Koda, M; Kucharczuk, W; Lesniewicz, T; Sulkowska, M; Sulkowski, S; Tomaszewski, J | 1 |
Azuma, K; Hashine, K; Miura, N; Numata, K; Sumiyoshi, Y | 1 |
Hayes, DF; Henry, NL | 1 |
Bondar, G; Kossé, V; Lehmann, U; Maubach, L; Meurer, J; Possinger, K; Schmid, P; Tarutinov, V; Untch, M; Vassiljev, L; Wallwiener, D | 1 |
Sauer, R; Sautter-Bihl, ML | 1 |
Aebi, S; Byrne, M; Castiglione-Gertsch, M; Coates, AS; Cole, BF; Colleoni, M; Crivellari, D; Gianni, L; Goldhirsch, A; Holmberg, SB; Pagani, O; Panzini, I; Price, KN; Ravaioli, A; Simoncini, E; Snyder, R | 1 |
Géczi, L | 1 |
Chen, L; Fan, Y; Fu, L; Guo, XJ; Lang, RG; Sun, YL | 1 |
Heidenreich, A; Jakse, G | 1 |
Debus, J; Milker-Zabel, S; Wannenmacher, M; Zabel-du Bois, A | 1 |
Hiraoka, M; Imagunbai, T; Inoue, T; Mitsumori, M; Negoro, Y; Sai, H; Sasaki, S; Sasaki, Y; Shikama, N; Takegawa, H; Teshima, T; Yamauchi, C | 1 |
Chow, NH; Tsai, YS; Tzai, TS | 1 |
Han, JQ; Li, XQ; Liang, RX; Liu, Q; Qu, FS; Sun, YH; Yan, TX | 1 |
Bafaloukos, D; Briasoulis, E; Dafni, U; Dimitrakakis, K; Dimopoulos, AM; Fountzilas, G; Gogas, H; Kalofonos, HP; Karanikiotis, C; Karina, M; Linardou, H; Makrantonakis, P; Markopoulos, C; Papadimitriou, C; Papakostas, P; Pectasides, D; Pisanidis, N; Polichronis, A; Samantas, E; Skarlos, D; Stathopoulos, GP; Tzorakoeleftherakis, E; Varthalitis, I; Xiros, N | 1 |
Fujikawa, A; Kawai, M; Moriyama, M; Ohta, J; Suwa, H; Takase, K; Ueki, T; Yokomizo, Y; Yumura, Y | 1 |
Andersson, M; Balil, A; Bendahmane, B; Buyse, M; Castiglione-Gertsch, M; Crown, J; Di Leo, A; Dolci, S; Francis, P; Gelber, RD; Goldhirsch, A; Gutiérrez, J; Jakesz, R; Jamin, S; Lang, I; Nordenskjöld, B; Piccart-Gebhart, M; van Hazel, G; Vorobiof, D | 1 |
Heidenreich, A | 1 |
Akashi-Tanaka, S; Ando, M; Fujiwara, Y; Hojo, T; Katsumata, N; Kinoshita, T; Kohno, T; Seki, K; Shibata, T; Shien, T; Shimizu, C | 1 |
Castiglione-Gertsch, M; Coates, AS; Cole, BF; Collins, J; Crivellari, D; Fey, MF; Gelber, RD; Goldhirsch, A; Golouh, R; Gruber, G; Gusterson, BA; Holmberg, SB; Lindtner, J; Price, KN; Simoncini, E; Thürlimann, B; Viale, G | 1 |
Ejlertsen, B; Jensen, MB; Mouridsen, HT | 1 |
Chen, WK; Chen, YF; Guo, ZM; Su, YR; Wei, MW; Wu, GH; Zeng, ZY | 1 |
Hills, WJ; Rufino, C; Stehlin, JS | 1 |
Bulbrook, RD; Bush, H; Crowther, D; Fentiman, IS; George, WD; Hayward, JL; Howat, JM; Howell, A; Rubens, RD; Sellwood, RA | 1 |
Merrin, CE | 1 |
Abratt, RP | 1 |
Cieplinski, W | 1 |
Ausekar, BV; Bychkov, MB; Perevodchikova, NI | 1 |
Abel, U; Beyer, JH; Herrmann, R; Holzmann, K; Schmieder, A; Spehn, J; von Franqué, U | 1 |
Fisher, B; Redmond, C; Wieand, HS | 1 |
Falkson, G; Falkson, HC; Glidewell, OJ; Henry, PH; Holland, JF; Leone, LA; Perloff, M; Tormey, DC; Weinberg, VE; Weiss, RB | 1 |
Fisher, B; Wolmark, N | 1 |
Carbone, PP | 1 |
Wood, WC | 1 |
Athens, JW; Costanzi, JJ; Foulkes, MA; Glucksberg, H; Knight, WA; O'Bryan, RM; Rivkin, SE; Stephens, RL | 1 |
Bartolucci, A; Ketcham, A; Liu, C; Marcial, V; Moore, M; Smalley, R; Velez-Garcia, E; Vogel, CL | 1 |
Eckert, C; Flynn, WJ; Gordon, NH; Hermann, RE; Hubay, CA; Jones, JC; Mansour, EG; Marshall, JS; McGuire, WL; Pearson, OH | 1 |
Jungi, WF | 1 |
Beadle, GF; Harris, JR | 1 |
Sledge, GW | 1 |
Gelber, RD | 1 |
Gray, R; Olson, JE; Taylor, SG; Tormey, DC | 1 |
Andersen, KW; Brincker, H; Fischerman, K; Mouridsen, HT; Rank, F; Rose, C; Thorpe, SM | 1 |
Brooks, RJ; Garewal, HS; Giordano, GF; Heusinkveld, RS; Jackson, R; Jones, SE; Kemmer, SR; Ketchel, SJ; Moon, TE; Takasugi, BJ | 1 |
Jones, SE; Moon, TE | 1 |
Tormey, C | 1 |
Foulkes, M; Glucksberg, H; Rivkin, SE | 1 |
Alberto, P; Barrelet, L; Brunner, KW; Cavalli, F; Jungi, WF; Mermillod, B | 1 |
Bonadonna, G; Brambilla, C; Rossi, A; Valagussa, P | 1 |
Baral, E; Beling, U; Carstensen, J; Friberg, S; Glas, U; Kaigas, M; Skoog, L; Wallgren, A | 1 |
Bulbrook, RD; Bush, H; Crowther, D; George, WD; Hayward, JL; Howat, JM; Howell, A; Knight, RK; Rubens, RD; Sellwood, RA | 1 |
Al'tshtuller, IuB; Besova, NS; Kurkina, TV; Voznyĭ, EK | 1 |
Amgwerd, R; Ammann, J; Creux, G; Enderlin, F; Engelhart, G; Heinz, C; Hochuli, E; Jungi, WF; Senn, HJ; Wick, A | 2 |
Goldhirsch, A | 1 |
Bonadonna, G; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U | 1 |
Cazzaniga, F; Clerici, R; Cosentino, D; Gallosi, D; Lattuada, N; Marelli, M; Scandolaro, L; Sgro, M; Sussi, PL | 1 |
Albrecht, M; Kleinkauf-Houken, A; Thomsen, K; Trams, G | 1 |
Ewert, G; Kinnman, J; Lundquist, PG; Ringborg, U; Strander, H | 1 |
Bartolucci, AA; Carpenter, J; Lefante, J; Marcial, V; Moore, M; Perez, CA; Smalley, RV; Velez-Garcia, E; Vogel, C; Wittliff, J | 1 |
Bian, AR; De Luca, L; Englaro, E; Englaro, GC; Geatti, O; Marsilio, P; Nadalin, L | 1 |
Airoldi, M; Badellino, F; Fazio, M; Gandolfo, S; Manca, A; Sannazzari, GL; Vercellino, V | 1 |
Clark, GM; McGuire, WL | 1 |
Czerwiński, W; Jurczyk-Procyk, S; Ordyniec, J; Perek, D | 1 |
Senn, HJ | 2 |
Fisher, B; Fisher, ER; Redmond, C | 1 |
Abramova, NA; Klykova, ID; Nivinskaia, MM | 1 |
Babayan, RK; deVere White, R; Krane, RJ; Krikorian, J; Olsson, CA | 1 |
Banfi, A; Bonadonna, G; Rossi, A; Tancini, G; Tess, JD; Valagussa, P | 1 |
Cooper, MR; Ferree, C; Howard, V; Jackson, DV; Muss, HB; Rhyne, AL; Richards, F; Shore, A; Spurr, CL; Stuart, JJ; White, DR | 1 |
Egger, H; Gunselmann, W; von Maillot, K | 1 |
Levitt, SH; Potish, RA | 1 |
Amgwerd, R; Hochuli, E; Jungi, WF; Senn, HJ | 1 |
Bajetta, E; Banfi, A; Bonadonna, G; Brambilla, C; Marchini, S; Rossi, A; Tancini, G; Tesoro Tess, JD; Valagussa, P; Veronesi, U | 1 |
Bonadonna, G; Brambilla, C; Marchini, S; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U | 1 |
Amgwerd, R; Ammann, J; Bigler, R; Creux, G; Enderlin, F; Engelhart, G; Heinz, C; Hochuli, R; Jungi, WF; Lanz, R; Seiler, S; Senn, HJ; Simon, B; Wick, A | 1 |
Carpenter, JT; Laws, HL; Maddox, WA; Soong, SJ; Wirtschafter, DD | 1 |
Athens, J; Costanzi, J; Gad-el-Mawla, N; Glucksberg, H; Hoogstraten, B; Maloney, T; McCracken, J; Rasmussen, S; Rivkin, SE; Tranum, B; Vaughn, C | 1 |
Richter, P | 1 |
Lössl, HJ; von Rottkay, P | 1 |
Reinfuss, M; Skołyszewski, J | 1 |
Albrecht, M; Jepsen, G; Thomsen, K; Trams, G | 1 |
Cantwell, B; Fennelly, JJ; Jones, M | 1 |
Goldobenko, GV; Kudriavtseva, GT; Mardynskiĭ, IuS; Seniukov, MV | 1 |
Brunner, KW; Goldhirsch, A; Joss, R; Sonntag, RW; Tschopp, L | 1 |
Denz, H; Huber, H; Kratzer, H; Michlmayr, G | 1 |
Goodyear, MD; Mackay, IR; Russell, IS | 1 |
Clark, GM; Knight, WA; McGuire, WL; Osborne, CK | 1 |
Cooper, RG; Glidewell, O; Holland, JF | 2 |
Kreienberg, R; Melchert, F; von Nathusius, U | 1 |
Ermilova, VD; Sokolova, IG | 1 |
Altug, U; Erol, D; Germiyanoğlu, C; Horasanli, K | 1 |
Algermissen, B; Czarnetzki, BM; Kohlmus, CM; Schadendorf, D; Worm, M | 1 |
Kawai, T; Kawakami, S; Ohno, Y; Tachibana, Y; Ueda, T; Yamauchi, T; Yonese, J | 1 |
Eiermann, W; Harbeck, N; Pache, L; Untch, M | 1 |
Lie, JT; Zimmer-Galler, I | 1 |
Hikosaka, A; Kobayashi, H; Obata, K; Takaba, H; Yokoi, K | 1 |
Igawa, M; Kadena, H; Ueda, M; Usui, T | 1 |
Berkowitz, LD; Love, N | 1 |
Ebuchi, M; Katada, M; Maruyama, M; Sugano, N; Takamatsu, S | 1 |
Asano, K; Kawahara, M; Masuda, F; Shirakawa, H | 1 |
Amoroso, D; Bertelli, G; Bruzzi, P; Campora, E; Del Mastro, L; Pronzato, P; Queirolo, P; Sertoli, MR; Venturini, M; Vigani, A | 1 |
Baba, S; Deguchi, N; Miyakawa, A; Murai, M; Nakamura, K; Nakashima, J; Tachibana, M; Tazaki, H | 1 |
Sack, H | 1 |
Xu, T | 1 |
Adachi, Y; Ayabe, K; Funahashi, S; Iso, Y; Konishi, J; Matsukuma, A; Moriyama, M; Sakino, I; Yo, R | 1 |
Gertenbach, U; Hohenfellner, R; Huber, C; Meyenburg, W; Stöckle, M; Thüroff, JW; Voges, G; Wellek, S | 1 |
Hosaka, M; Ikeda, I; Kubota, Y; Shuin, T; Yao, M | 1 |
Bliss, J; Coombes, RC; Marty, M; Wils, J; Woods, E | 1 |
Fujii, A; Gohji, K; Hasunuma, Y; Higuchi, A; Itoh, N; Izumi, T; Maruyama, S; Minayoshi, K; Tanaka, H | 1 |
Abeloff, MD; Budd, GT; Green, S; Hahn, R; Harris, J; Martino, S; O'Bryan, RM; O'Sullivan, J; Rinehart, JJ; Tormey, D | 1 |
Berger, A; Budinsky, AC; Eibl, M; Krainer, M; Kubista, E; Müller, C; Speiser, P; Wiltschke, C; Zeillinger, R; Zielinski, CC | 1 |
Clahsen, PC; Sylvester, RJ; van de Velde, CJ; van Driel, OJ; Welvaart, K | 1 |
Cheng, DL; Fine, EM; Forscher, CA; Unger, P | 1 |
Castiglione-Gertsch, M; Collins, J; Cortes-Funes, H; Forbes, J; Gelber, RD; Goldhirsch, A; Hacking, A; Johnsen, C; Lindtner, J; Rudenstam, CM | 1 |
Bonadonna, G; Valagussa, P; Zambetti, M | 1 |
Barraclough, B; Boyages, J; Langlands, AO; Ung, O | 1 |
Bonadonna, G; Brambilla, C; Moliterni, A; Valagussa, P; Zambetti, M | 1 |
Bastert, G; Beyerle, C; Bojar, H; Hübner, K; Neumann, RL; Olschewski, M; Rauschecker, HF; Sauerbrei, W; Schmoor, C; Schumacher, M | 1 |
Abeloff, MD; Costanzi, JJ; Cruz, AB; Farrar, WB; Green, S; Jewell, WR; Metch, B; Minton, JP; Osborne, CK; Rivkin, SE | 1 |
Korovin, SI; Naleskina, LA; Tolstopiatov, BA | 1 |
Korovin, SI; Tolstopiatov, BA | 2 |
Gertenbach, U; Hohenfellner, R; Huber, C; Meyenburg, W; Rossmann, M; Stöckle, M; Thüroff, JW; Voges, GE; Wellek, S | 1 |
Sauter, C | 1 |
Kobayashi, H; Obata, K | 1 |
Fechner, RE; Frierson, HF | 1 |
Hagiwara, A; Ohyama, T; Osaki, K; Sakakura, C; Sawai, K; Takahashi, T; Tomoda, H; Tsujimoto, H; Yamaguchi, M; Yamamoto, A | 1 |
Galakhin, KA; Koval'chuk, EN; Vorob'eva, LI | 1 |
Renner, H; van Kampen, M | 1 |
Daubner, D; Lõrincz, I; Pályi, I; Péter, I; Vincze, B | 1 |
Lopez, AE; Lu, Y; Patel, J; Soloway, MS | 1 |
de Graaf, H; de Vries, EG; Dolsma, WV; Mulder, NH; Mulder, PO; Sleijfer, DT; Smit Sibinga, CT; van der Graaf, WT; van der Ploeg, E; Willemse, PH | 1 |
Argüello, A; Barrantes, JC; Barrantes, M; García, I; Jiménez, R; Lobo-Sanahuja, F | 1 |
Balaban, EP; Bull, J; Frenkel, EP; Graham, M; Periman, P; Perkins, S; Pruitt, B; Ross, M; Ruud, C; Sheehan, RG | 1 |
Anai, H; Furuyama, M; Ikejiri, K; Maekawa, S; Muranaka, T; Saku, M; Takeo, S; Yakabe, S | 1 |
Bari, M; Bruscagnin, G; Gatti, C; Gion, M; Leon, AE; Mione, R; Nascimben, O; Pappagallo, GL; Vinante, O | 1 |
Altman, SJ; Costanzi, JJ; Green, S; Jewell, WR; Metch, B; Minton, JP; O'Bryan, RM; Osborne, CK; Rivkin, SE | 1 |
Akiyama, T; Kiriyama, M; Kita, I; Kosaka, T; Nakagawa, T; Nakano, Y; Saito, H; Takano, Y; Takashima, S; Tomita, F | 1 |
Abel, U; Brunnert, K; Caffier, H; Hilfrich, J; Jonat, W; Kaufmann, M; Kleine, W; Kreienberg, R; Schermann, J; Trams, G | 1 |
Coussens, D; Koch, MO | 1 |
de Vries, EG; Dolsma, WV; Mulder, NH; Mulder, PO; Sleijfer, DT; van der Ploeg, E; Willemse, PH | 1 |
Canellos, GP; Frei, E; Gelman, RS; Hayes, DF; Henderson, IC; Obando, A; Osteen, R; Shapiro, CL | 1 |
Arrigoni, F; Poletti, EM; Sacco, R; Saturno, F; Ventriglia, L | 1 |
Ben-Dor, CG; Brufman, G; Isacson, R; Safra, T; Uziely, B | 1 |
Abeloff, MD; Falkson, G; Falkson, HC; Gilchrist, K; Gray, R; Tormey, DC | 1 |
Akashi, S; Fukutomi, T; Nanasawa, T; Yamamoto, H | 1 |
Aapro, M; Amadori, D; Bliss, JM; Chilvers, CE; Coombes, G; Coombes, RC; Espié, M; Ferreira, EP; Gambrosier, P; Marty, M; McArdle, C; Morvan, F; Pérez-López, FR; Richards, M; Vassilopoulos, P; Villar-Grimalt, A; Wils, J; Woods, EM | 1 |
Abeloff, MD; Costanzi, JJ; Cruz, AB; Farrar, WB; Green, S; Jewell, WR; O'Sullivan, J; Osborne, CK; Rivkin, SE | 1 |
Clahsen, PC; Delozier, T; Floiras, JL; Julien, JP; Mignolet, FY; Sahmoud, TM; van de Velde, CJ | 1 |
Johnson, JT; Myers, EN; Wagner, RL | 1 |
Arriagada, R; Fontaine, F; Le Chevalier, T; Mouriesse, H; Spielmann, M; Thomas, F; Tursz, T | 1 |
Belpomme, D; Chollet, P; Delgado, M; di Palma, M; Fargeot, P; Fumoleau, P; Guerrin, J; Hill, C; Ithzaki, M; Le Mevel, B; Mathé, G; Metz, R; Misset, JL; Plagne, R | 1 |
Ganssauge, F; Plasswilm, L; Sauer, R; Seegenschmiedt, MH | 1 |
Hudis, CA | 1 |
Abramson, N; Aron, BS; Atkins, JN; Bowman, DM; Costantino, JP; Dignam, J; Dimitrov, NV; Fisher, B; Glass, AG; Mamounas, EP; Margolese, RG; Redmond, C; Sutherland, CM; Wickerham, DL; Wolmark, N | 1 |
Bernier, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A; Joseph, D; Roncadin, M; Wallgren, A | 1 |
Everington, D; Forrest, AP; George, WD; Harnett, AN; McArdle, CS; Prescott, RJ; Smith, DC; Stewart, HJ | 1 |
Becagli, P; Messori, A; Tendi, E; Trippoli, S | 1 |
Fujimoto, H; Kakizoe, T; Kume, H; Niwakawa, H; Tobisu, K; Tomita, K; Tsutsumi, M; Yuen, K | 1 |
Hagiwara, A; Hoshima, M; Imanishi, T; Muranishi, S; Ohgaki, M; Ohyama, T; Sakakura, C; Sawai, K; Takahashi, T; Yamamoto, A | 1 |
Martus, P; Sauer, R | 1 |
Gupta, NK; Slevin, NJ; Swindell, R; Turner, SL | 1 |
Katai, H; Maruyama, K; Noda, N; Ono, H; Sano, T; Sasako, M; Shirao, K | 1 |
Imamura, M; Maetani, S; Nishitai, R; Onodera, H; Shimizu, K | 1 |
Fehm, T; Jäger, W; Katalinic, A; Maimonis, P; Teramoto, Y; Weitz, S | 1 |
Hagiwara, A; Imanishi, T; Kitamura, K; Ohgaki, M; Sakakura, C; Shirasu, M; Takahashi, T; Yamasaki, J | 1 |
Bünemann, H; Heilmann, HP; Janik, I; Willers, H; Würschmidt, F | 1 |
Comley, M; Engels, K; Fox, SB; Gatter, KC; Harris, AL; Turley, H; Whitehouse, RM | 1 |
Gates, J; Levine, P; Maiman, M; Mathews, RP; Remy, JC; Serur, E | 1 |
Arai, K; Iwasaki, Y; Kitamura, M | 1 |
Castiglione, M; Cavalli, F; Jungi, WF; Leyvraz, S; Maibach, R; Obrecht, JP; Schildknecht, O; Senn, HJ; Siegenthaler, P | 1 |
Inaji, H; Koyama, H; Motomura, K; Noguchi, S | 1 |
Brenner, B; Fenig, E; Hana, MB; Katz, A; Rakovsky, E; Sulkes, A | 1 |
Dees, EC; Shulman, LN; Smith, BL; Souba, WW | 1 |
Fujimori, Y; Iki, K; Imai, H; Iwamoto, S; Kawasaki, S; Kimoto, M; Kubozoe, T; Murakami, T; Mure, T; Onuma, E; Tadaoka, Y; Takeo, T; Tsunoda, T; Yamamoto, Y; Yoshida, K | 1 |
Arai, Y; Kinouchi, T; Kotake, T; Kuroda, M; Usami, M | 1 |
Hagiwara, A; Imanishi, T; Ohgaki, M; Sakakura, C; Sawai, K; Shirasu, M; Takahashi, T; Taniguchi, H; Togawa, T; Yamaguchi, T; Yamasaki, J | 1 |
Imoto, S | 1 |
Abramson, N; Atkins, JN; Bryant, J; DeCillis, A; Deschenes, L; Dignam, J; Dimitrov, NV; Emir, B; Fisher, B; Margolese, RG; Shibata, H; Wickerham, DL; Wolmark, N | 1 |
Andersson, M; Bach, F; Gadeberg, CC; Hansen, PS; Jensen, MB; Kjaer, M; Mouridsen, HT; Overgaard, J; Overgaard, M; Rose, C; Zedeler, K | 1 |
Agostara, B; Amoroso, D; Boccardo, F; Farris, A; Gallo, L; Mesiti, M; Pacini, P; Perrotta, A; Rubagotti, A; Sismondi, P; Villa, E | 1 |
Becagli, P; Messori, A; Trippoli, S | 1 |
Arcangeli, G; Comandini, E; D'Angelo, L; D'Aprile, M; Giovinazzo, G; Lopez, M; Mauri, M; Micheli, A; Scala, T; Tersigni, R | 1 |
Sakata, Y; Tsushima, K | 1 |
Bourstyn, E; de Cremoux, P; de Roquancourt, A; Degeorges, A; Espie, M; Extra, JM; Marty, M; Soussi, T | 1 |
Akamine, T; Hanada, N; Hiraoka, T; Hongo, H; Kitamura, N; Kondo, K; Mori, T; Tabira, Y; Toyota, N; Yoshioka, M | 1 |
Iki, K; Iwamoto, S; Kawasaki, S; Kimoto, M; Kubozoe, T; Majima, T; Mure, T; Onuma, E; Tadaoka, Y; Tsunoda, T; Yamamoto, Y; Yoshida, K | 1 |
Buckner, JC; Lewis, JE; McElroy, EA | 1 |
Barentsz, JO; Berger-Hartog, O; Hulsbergen-van der Kaa, C; Kondacki, H; Oosterhof, GO; Ruijs, SH; VanderLaak, JA; Witjes, JA | 1 |
Beuzeboc, P; Christoforov, B; Debré, B; Dhote, R; Flam, T; Thiounn, N; Zerbib, M | 1 |
Heidemann, E | 1 |
Korovin, SI | 1 |
Fradet, Y | 1 |
Hagiwara, A; Hirata, Y; Takahashi, T | 1 |
Cao, Z; Peng, Z; Zhang, D | 1 |
Hato, T; Kaneda, N; Murase, K; Sato, T; Shimokawa, K; Takahashi, C; Takeuchi, T; Tsuya, H | 1 |
Abeloff, MD; Cella, D; Citron, ML; Fairclough, DL; Fetting, JH; Gray, R; Grove-Conrad, M; Henderson, IC; Margolin, KA; Osborne, CK; Pandya, K; Robert, N; Smith, TJ | 1 |
Das Gupta, TK; Hieken, TJ; Marler, KC; McDermott, JH; Mehta, RR; Patel, MK; Wild, LD | 1 |
Akiyama, T; Kita, I; Kosaka, T; Nakano, Y; Saito, H; Sugaya, J; Takashima, S; Tomita, F; Ueshige, N | 1 |
Abu-Zahra, H; Arnold, A; Bowman, D; Bramwell, VH; Burnell, M; Findlay, B; Levine, MN; MacKenzie, R; Myles, J; Norris, BD; Ottaway, J; Pritchard, KI; Robert, J; Shepherd, LE; Tu, D; Vandenberg, T; Warr, D; Williams, CK | 1 |
Castiglione, M; Cavalli, F; Coates, A; Collins, J; Crivellari, D; Fey, M; Gelber, RD; Goldhirsch, A; Lindtner, J; O'Neill, A; Pagani, O; Price, K; Rudenstam, CM; Senn, HJ; Simoncini, E; Thürlimann, B | 1 |
Barbareschi, M; Bevilacqua, P; Boracchi, P; Caffo, O; Doglioni, C; Gasparini, G; Mauri, FA; Morelli, L; Palma, PD; Verderio, P | 1 |
Ayala, A; Ferguson, WS; Gieser, P; Goorin, AM; Harris, MB; Holbrook, T; Link, MP; Shochat, SJ | 1 |
Atkins, CD | 1 |
Castiglione-Gertsch, M; Coates, A; Colleoni, M; Collins, J; Gelber, RD; Goldhirsch, A; Lindtner, J; Price, K; Rudenstam, CM; Thürlimann, B | 1 |
Delbos, O; Guiter, J; Legouffe, E; Navratil, H; Robert, M; Sahwi, A | 1 |
Abeloff, MD; Davidson, NE; Donehower, RC; Fetting, JH; Kennedy, MJ; Mikhak, B; Waterfield, W; Zahurak, M | 1 |
Birch, R; Buckner, CD; Greco, FA; Hainsworth, J; Leff, R; McAneny, B; Raefsky, E; Schwartzberg, LS; Tauer, KW; Weaver, CH; Weaver, Z; West, J | 1 |
Adjei, AA; Ingle, JN; Rayson, D; Suman, VJ; Wold, LE | 1 |
Barnes, DM; Gillett, CE; Harris, WH; Miles, DW; Smith, P | 1 |
Görlich, M; Jandrig, B | 1 |
Blomqvist, C; Joensuu, H; Lundin, J; Poikonen, P; Saarto, T | 1 |
Nekhme, A | 1 |
Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
Allred, DC; Ashley, SE; Assersohn, L; Chang, J; Clark, GM; Dowsett, M; Gregory, RK; Makris, A; Osborne, CK; Powles, TJ | 1 |
Agostinelli, R; Baldelli, AM; Barni, S; Cascinu, S; Catalano, G; Catalano, V; Frontini, L; Gasparini, G; Giuliodori, L; Labianca, R; Martignoni, G; Mattioli, R; Silva, RR | 1 |
Nasu, K; Nishimura, M; Ohta, H; Shintaku, M; Takahashi, Y | 1 |
Fridrik, M; Gnant, M; Haider, K; Hausmaninger, H; Jakesz, R; Kolb, R; Kubista, E; Manfreda, D; Mittlböck, M; Mlineritsch, B; Samonigg, H; Steger, G; Steindorfer, P; Stierer, M; Tschurtschenthaler, G | 1 |
Huang, XY; Ishigooka, M; Kubota, Y; Nakada, T; Sasagawa, I; Suzuki, H | 1 |
Barenbrock, M; Berdel, WE; Dietrich, M; Kisters, K; Matzkies, FK; Rahn, KH; Schaefer, RM; Tombach, B | 1 |
Bando, H; Kanno, M; Kawahara, F; Mura, T; Nakamura, S; Noguchi, M; Taniya, T; Tsugawa, K; Uotani, C | 1 |
Karemaker, JM; Lenders, JW; Timmers, HJ; Wieling, W | 1 |
Andersen, J; Andersson, M; Cold, S; Dombernowsky, P; Ejlertsen, B; Jensen, MB; Kamby, C; Kjaer, M; Mouridsen, H; Overgaard, M; Rose, C | 1 |
Bartholomeus, S; Crown, J; Di Leo, A; Dolci, S; Duffy, K; Larsimont, D; Nogaret, JM; O'Higgins, N; Paesmans, M; Piccart, MJ; Riva, A; Rowan, S | 1 |
Blohmer, J; Breitbach, P; Elling, D; Heinrich, J; Köhler, U; Kohls, A; Krocker, J; Kümmel, S; Lichtenegger, W; Quass, J | 1 |
Amonkar, AJ; D'cruz, AK; Juvekar, AS; Pradhan, S; Saikaia, T | 1 |
Bos, AM; de Graaf, H; de Vries, EG; Piersma, H; Willemse, PH | 1 |
Bonadonna, G; Cipriani, S; Daidone, MG; Luisi, A; Silvestrini, R; Valagussa, P; Zambetti, M | 1 |
Ragaz, J; Spinelli, JJ | 1 |
Han, Q; Shen, K; Shen, Z | 1 |
Ando, J; Fujisaki, M; Ikeda, T; Imoto, S; Kobayashi, H; Kojima, M; Oka, S; Tamura, H; Wada, N | 1 |
Espié, M; Henry-Amar, M; Héron, JF; Joly, F; Marty, M | 1 |
Amadori, D; Becciolini, A; Catalano, G; Gambi, A; Giunchi, DC; Marangolo, M; Nanni, O; Pacini, P; Perroni, D; Ravaioli, A; Rossi, A; Scarpi, E; Tienghi, A; Volpi, A | 1 |
Kitaoka, A; Ohsumi, K; Tokuka, A; Tokunaga, Y; Yagi, T | 1 |
Abramson, N; Anderson, S; Atkins, JN; Dimitrov, NV; Farrar, WB; Fisher, B; Fisher, ER; Kardinal, CG; Margolese, RG; Merajver, S; Romond, EH; Shibata, HR; Tan-Chiu, E; Wickerham, DL; Wolmark, N | 1 |
Biganzoli, E; Bonadonna, G; Boracchi, P; Casalini, P; Cascinelli, N; Colnaghi, MI; Gianni, L; Marubini, E; Ménard, S; Pilotti, S; Tomasic, G; Valagussa, P | 1 |
Allred, DC; Dressler, LG; Gray, R; Hatfield, AK; Martino, S; Page, DL; Robert, NJ; Wood, WC | 1 |
Hoshi, S; Kaihou, Y; Namima, T; Ohyama, C; Orikasa, S; Sato, K; Satoh, M; Shintaku, I; Suzuki, KI | 1 |
Hoshi, S; Ishidoya, S; Kaihou, Y; Namima, T; Ohyama, C; Orikasa, S; Shintaku, I; Suzuki, K; Takahashi, T | 1 |
Chen, IH; Chen, JS; Liaw, CT; Ng, SH; Wang, CH; Wang, HM; Yang, TS | 1 |
Mazeron, JJ; Noël, G | 1 |
Bastert, G; Bojar, H; Sauerbrei, W; Schmoor, C; Schumacher, M | 1 |
Brzozowska, A; Mazurkiewicz, M; Szatkowska, L | 1 |
Mayers, C; Panzarella, T; Tannock, IF | 1 |
Borovik, R; Brenner, HJ; Brenner, J; Brufman, G; Catane, R; Chaitchik, S; Dale, A; Farbstein, H; Inbar, MJ; Rizel, S; Ron, IG; Shani, A; Wigler, N | 1 |
Abzumanov, AS; Barash, NIu; Bozhok, AA; Ivanov, VG; Ivanova, OA; Migmanova, NSh; Nurgaziev, KSh; Popova, RT; Seleznev, IK; Semiglazov, VF; Topuzov, EE | 1 |
Arick, CL; Hutchins, LF | 1 |
Baba, H; Ebuchi, M; Kure, N; Maruyama, M; Nagahama, T; Tokairin, Y; Yoshida, T | 1 |
Glück, S | 1 |
Hathaway, B; Johnson, JT; Labriola, S; Myers, EN; Piccirillo, JF; Snyderman, CH; Wagner, RL | 1 |
Ahn, SH; Bae, BN; Han, S; Kim, HJ; Kim, HY; Kim, KH; Kim, YD; Park, K | 1 |
Branković-Magić, M; Janković, R; Nesković-Konstantinović, Z; Nikolić-Vukosavljević, D | 1 |
Dillon, JJ; Fleming, GF; Hartman, AR | 1 |
Bergauer, F; Dimpfl, T; Janni, W; Kaestner, R; Linka, F; Rack, B; Rjosk, D; Schindlbeck, C; Sommer, H; Strobl, B | 1 |
Kleeberg, UR | 1 |
Illiger, HJ; Ost, E | 1 |
Ioka, Z; Nakane, Y; Nakano, K; Osaka, Y; Sako, H; Takemura, N; Tanabe, S; Tsuchiya, K | 1 |
Blackstock, AW; Case, D; Higgs, V; Melin, SA; Savage, P; Tomlinson, SK; White, DR | 1 |
Awada, A; Bartholomeus, S; Beauduin, M; Cardoso, F; Di Leo, A; Dolci, S; Ferreira Filho, AF; Focan, C; Michel, J; Paesmans, M; Piccart, MJ; Vindevoghel, A | 1 |
Cardi, A; Di Silverio, F; Fattore, F; Gentile, V; Mariotti, G | 1 |
Just-Viera, JO; Silva, JE | 1 |
Carter, SK; Goldsmith, MA | 1 |
Arthur, K; Banks, AJ; Bond, WH; Brown, I; Chowdhury, MS; Freeman, WE; Holme, GM; Jones, WG; Newsholme, GA; Ward, HW | 1 |
Carter, SK; Wasserman, TH | 1 |
Davis, TE; Rose, DP | 1 |
Holland, JF | 3 |
Engeler, V; Otto, R; Zwicker, H | 1 |
Aisner, J; Elias, EG; Morris, D; Wiernik, PH | 1 |
Bitran, JD; Matz, G; Toledo-Pereyra, LH | 1 |
Brunner, KW | 1 |
Dombernowsky, P; Hansen, HH | 1 |
Cassady, RJ; Filler, RM; Jaffe, N; Murray, J; Traggis, D; Watts, H; Weichselbaum, R; Weinstein, H | 1 |
Astedt, B; Gynning, I; Mattsson, W; Tropé, C | 1 |
Banfi, A; Bonadonna, G; Rossi, A; Valagussa, P; Veronesi, U | 1 |
Fisher, B | 3 |
Caffier, H; Rotte, K | 1 |
Bonadonna, G; Rossi, A; Valagussa, P | 1 |
Bonadonna, G; Rossi, A; Valagussa, P; Veronesi, U | 1 |
Amgwerd, R; Bigler, R; Creux, G; Enderlin, F; Engelhart, G; Heinz, C; Hochueli, R; Jungi, WF; Lanz, R; Senn, HJ; Simeon, B; Sprenger, F; Wick, A | 1 |
Borisov, AI | 1 |
Engelsman, E; Hamersma, E; Schaake, C | 1 |
Arwidi, A; Lindholm, CE; Mattsson, W; von Eyben, F | 1 |
Assekritova, IV; Gorbunova, VA; Lichinitser, MR | 1 |
Carey, RW; Halpern, E; Kaufman, S; Kelley, RM; Lew, RA; Sohier, WD; Weitzman, SA | 1 |
Broggini, M; Colombo, T; Donelli, MG; Garattini, S | 1 |
Kaufmann, M; Kubli, F; Reus, W; Volm, M; von Fournier, D | 1 |
Neiger, M; Veraguth, P | 1 |
Block, GE; DeSombre, E; Ellis, RS; Jensen, E | 1 |
Sveinsson, T; von der Maase, H | 1 |
Couly, B; Luboinski, B; Schwaab, G; Vandenbrouck, C | 1 |
Vahlensieck, W; Weissbach, L | 1 |
Bonadonna, G; Rossi, A; Veronesi, U | 1 |
Iavorskiĭ, VV; Kadagidze, ZG; Kupin, VI; Malaev, SG; Trapeznikov, NN | 1 |
Brown, AS; Hamilton, RW; Horstmann, JT; Johnson, JL; Rosato, FE; Wallack, MK | 1 |
Morton, DL; Ramming, KP; Silver, HK; Sparks, FC; Wile, AG; Wolk, RW | 1 |
Band, PR; Carbone, PP | 1 |
Cassady, JR; Filler, RM; Frei, E; Jaffe, N; Traggis, D; Watts, H | 1 |
Bruntsch, U; Gallmeier, WM; Schmidt, CG | 1 |
Catalano, RB; Creech, RH; Engstrom, PF; Mastrangelo, MJ | 1 |
Bajetta, E; Bonadonna, G; Brambilla, C; Brugnatelli, L; Brusamolino, E; De Lena, M; Musumeci, R; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U | 1 |
Iachmeneva, NF; Medvedev, ES; Vtiurin, BM | 1 |
Fujieda, S; Ohtsubo, T; Saito, H; Tanigawa, N | 1 |
Bavli, IaL; Chepik, OF; Golubeva, OM; Ivanova, OA; Orlov, AA; Seleznev, IK; Semiglazov, VF; Topuzov, EE | 1 |
Eagan, RT; Feldman, ER; Schaid, DJ | 1 |
Buzdar, AU; Jaiyesimi, IA | 1 |
Basco, V; Kuusk, U; Rebbeck, P | 1 |
Ezaki, K; Maeda, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Sobue, R; Tsuzuki, M; Wakita, M | 1 |
Bartolucci, AA; Bass, D; Carpenter, JT; Ketcham, A; Marcial, V; Moore, M; Singh, KP; Smalley, R; Vélez-García, E; Vogel, CL | 1 |
Albain, KS; Green, S; LeBlanc, M; O'Sullivan, J; Osborne, CK; Rivkin, S | 1 |
Igawa, M; Ohkuchi, T; Ueda, M; Usui, T | 1 |
Conti, R; Cusumano, F; Grassi, M; Rovini, D; Salvadori, B; Squicciarini, P | 1 |
Hagiwara, A; Okano, S; Ozaki, K; Sakakura, C; Sasaki, S; Sawai, K; Shimotsuma, M; Shirasu, M; Takahashi, T; Tsujimoto, H | 1 |
Bonadonna, G | 2 |
Calabrese, F; Correggia, F; Giacomasso, S; Miozzo, S; Negri, L | 1 |
Amoroso, D; Boccardo, F; Castagnetta, L; Farris, A; Genta, F; Nenci, I; Piffanelli, A; Rubagotti, A; Sismondi, P; Traina, A | 1 |
Boyages, J; Driessen, C; Langlands, AO; Lindeman, GJ | 1 |
Jungi, WF; Senn, HJ | 1 |
Bignami, P; Bonadonna, G; Contesso, G; Coradini, D; Daidone, MG; Silvestrini, R; Valagussa, P; Zambetti, M | 1 |
Grieve, RJ; Howell, A; Kelly, KA; Monypenny, IJ; Morrison, JM; Walker, RA; Waterhouse, JA | 1 |
Cooper, MR; Eudey, L; Falkson, G; Gilchrist, KW; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC | 1 |
Demirkazik, A; Dinçol, D; Günel, N; Içli, F; Karaoğuz, H | 1 |
Andreola, S; Baldini, MT; Bufalino, R; Cascinelli, N; Galluzzo, D; Greco, M; Leo, E; Morabito, A; Rilke, F; Testori, A | 1 |
Baiocchi, G; Battaglia, F; Conte, M; Gallo, A; Greggi, S; Laurelli, G; Panici, PB; Rabitti, C; Ragusa, G; Scambia, G | 1 |
Connors, JM; Hoskins, PJ; Klimo, P; Ng, V; Spinelli, JJ | 1 |
Bagshawe, KD; Begent, RH; Bradley, J; Dawson, PM; Kulkarni, RP; Makey, AR; Newlands, ES; Reynolds, KW; Rustin, GJ; Theodorou, NA | 1 |
Cousar, JB; Flexner, JM; Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Stein, RS; Wolff, SN | 1 |
Amato, R; Dexeus, FH; Fitz, K; Kilbourn, R; Logothetis, CJ; Sella, A; Striegel, A | 1 |
Cartwright, KC; Duncan, MH; Foucar, E; McConnell, TS; Winter, SS | 1 |
Abu-Zahra, H; Arnold, A; Bramwell, V; Findlay, B; Gent, M; Goodyear, MD; Levine, MN; Skillings, J | 1 |
Brockschmidt, JK; Cooper, MR; Ferree, C; Jackson, DV; Muss, HB; Richards, F; Spurr, CL; White, DR | 1 |
Bombino, T; Brambilla, C; Ferrari, L; Gangeri, L; Rosso, S; Tamburini, M | 1 |
Allen, S; Bosworth, H; Budman, D; Lehrman, D; Lichtman, SM; Schulman, P; Vinciguerra, V; Weiselberg, L; Weiss, R | 1 |
Raabe, NK | 1 |
Bonadonna, G; Buzzoni, R; Valagussa, P; Zambetti, M | 1 |
Frischbier, HJ; Maass, H; Schreer, I; Stegner, HE | 1 |
Boogerd, W; Engelsman, E; Hart, AA; van der Sande, JJ | 1 |
Clendeninn, NJ; Collier, MA; Dimery, IW; Eble, ML; Jacobs, CD; Karp, D; Molina, A; Vokes, EE | 1 |
Bonadonna, G; Ferrari, L; Moliterni, A; Valagussa, P; Zambetti, M | 1 |
Krishnamurthi, S; Shanta, V | 1 |
Ansari, R; Fisher, WB; Meyer, SC; Roth, BJ; Sledge, GW; Williams, SD | 1 |
Dumont, R; Guillem, V; Iborra, I; Monrós, JL; Ricós, JV; Solsona, E | 1 |
Bellorofonte, C; Dell'Acqua, S; Ferri, PM; Gozo, M; Gritti, A; Morosini, D; Ruoppolo, M; Tiraboschi, B; Tura, M; Zaatar, C | 1 |
Camplejohn, RS; Millis, RR; O'Reilly, SM; Richards, MA; Rubens, RD | 1 |
Bader, J; Danforth, DN; Egan, E; Lampert, M; Lippman, ME; McDonald, H; Steinberg, SM; Swain, SM | 1 |
Brendler, CB; Burgers, JK; Epstein, JI; Marshall, FF; Oesterling, JE | 1 |
Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH | 1 |
Boccardo, F; Bruzzi, P; Cappellini, M; Isola, G; Nenci, I; Piffanelli, A; Rubagotti, A; Santi, L; Scanni, A; Sismondi, P | 1 |
Andriani, A; Beni, A; Patino, N; Rinaldi, P; Zampa, G | 1 |
Fuchs, U; Merkle, E; Sauerbrei, W; Seidl, C; Wirtz, PM | 1 |
Kato, T; Koshikawa, T; Miyake, K; Nagai, T; Sahashi, M; Sakata, T; Takashi, M | 1 |
Dinçol, D; Içli, F; Isikman, E; Unal, M | 1 |
Al'tshuler, IuB; Melent'eva, EG; Meshcheriakova, NG; Voznyĭ, EK | 1 |
Arakawa, S; Gohji, K; Gotoh, A; Hamami, G; Hara, I; Itani, A; Kamidono, S; Matsumoto, O; Ogawa, T; Takenaka, A | 1 |
Donovski, L; Kumanov, Kh; Ormanov, I; Panchev, P; Tsvetkov, M | 1 |
Goseki, N; Ide, H; Iwatsuka, M; Koike, M; Konisi, T; Kosaki, G; Sasaki, T; Suzuki, T | 1 |
Miyahara, H; Sato, T; Tsuruta, Y; Umatani, K; Yoshino, K | 1 |
Krusinski, PA; Nunnink, JC; Yates, JW | 1 |
Advani, SH; Desai, PB; Dinshaw, KA; Gopal, R; Pinto, JM; Saikia, TK; Sharma, S; Swaroop, VS; Vyas, JJ | 1 |
Deitmer, T; Urbanitz, D | 1 |
Chauvergne, J; Richaud, P; Traissac, L | 1 |
Adelstein, DJ; Davis, BR; Hines, JD; Zakem, MH | 1 |
Böheim, K; Lochs, A; Picker, H; Spoendlin, H; Zingerle, N | 1 |
Klima, A; Klippstein, T; Szepesi, S; von Ilberg, C | 1 |
Headley, DL; Retsky, MW; Swartzendruber, DE; Wardwell, RH | 1 |
Dawson, P; Dean, L; Nachman, J; Shermeta, D; Simon, MA; Vogelzang, NJ | 1 |
Bassot, V; Bonfils, P; Brasnu, D; Fabre, A; Janot, F; Laccourreye, H; Ménard, M | 1 |
Bassot, V; Brasnu, D; Fabre, A; Janot, F; Laccourreye, H; Ménard, M | 1 |
Bianco, AR; Gridelli, C; Palmieri, G; Vitale, A | 1 |
Piva, L; Pizzocaro, G | 1 |
Benedetti Panici, P; Greggi, S; Mancuso, S; Scambia, G | 1 |
Brázda, A; Jansa, P; Pastrnák, A; Podstata, J | 1 |
Hiratsuka, H; Kohama, G; Kumagai, S; Miyakawa, A; Yamamoto, E | 1 |
Barton, JC | 1 |
Andry, G; Buyse, M; Chantrain, G; Dodion, PF; Dor, P; Haesendonck, P; Larsimont, D; Lemort, M; Recloux, P; Van Houtte, P | 1 |
Baba, T; Furukohri, N; Itoh, T; Munakata, A; Ogasawara, H; Saitoh, S; Sakata, Y; Tamura, Y; Tsushima, K; Yoshida, Y | 1 |
Perevodchikova, NI | 1 |
Benfield, GF; Collins, FJ; Cullen, MH; Matthews, HR; Watson, DC | 1 |
Gertner, K; Mikhina, ZP; Motorina, LI; Trofimova, NB | 1 |
Apple, JS; Baber, C; Paulson, DF; Putman, CE | 1 |
Gubareva, AA; Kindzel'skiĭ, LP; Perepechkina, VT; Usatenko, VD | 1 |
Amoroso, D; Bertelli, G; Botto, F; Campora, E; Conte, PF; Pronzato, P; Rosso, R; Sertoli, MR | 1 |
Høst, H; Kjellgren, K; Nissen-Meyer, R | 1 |
Bowman, D; Dimitrov, NV; Fisher, B; Fisher, ER; Legault-Poisson, S; Margolese, R; Redmond, C; Sutherland, C; Wickerham, DL; Wolmark, N | 1 |
Athens, J; Constanzi, JJ; Gad-el-Mawla, N; Glucksberg, H; Green, S; Hoogstraten, B; Maloney, T; Metch, B; Osborne, CK; Rivkin, SE | 1 |
Igawa, M; Kodama, M; Kume, T; Masu, C; Nakatsu, H; Ohnishi, Y; Okada, K; Ueda, M; Ueki, T; Usui, T | 1 |
Scheurlen, H | 1 |
Barett-Mahler, AR; Jungi, WF; Senn, HJ | 1 |
Cooper, MR | 1 |
Bychkov, MB; Gertner, K; Mikhina, ZP; Motorina, LI; Trofimova, NB | 1 |
Bianco, AR; D'Istria, M; De Placido, S; Delrio, G; Gallo, C; Marinelli, A; Pagliarulo, C; Petrella, G | 1 |
Cooper, MR; Falkson, G; Gilchrist, KW; Gray, R; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC | 1 |
Basco, VE; Knowling, MA | 1 |
Linsk, JA | 1 |
Hrafnkelsson, J; Nilsson, K; Söderberg, M | 1 |
Fowble, B; Glick, J; Goodman, R | 1 |
Peek, U | 1 |
Castiglione, M; Gelber, RD; Goldhirsch, A | 1 |
Bonadonna, G; Buzdar, A; Jones, SE; Montague, E; Moon, TE; Powles, T; Rivkin, S; Valagussa, P | 1 |
Bonadonna, G; Buzdar, A; Jones, SE; Montague, E; Moon, TE; Powles, T; Valagussa, P | 1 |
Andersen, KW; Brincker, H; Dombernowsky, P; Jakobsen, A; Mouridsen, HT; Panduro, J; Rank, F; Rose, C | 1 |
Cascinelli, N; Greco, M; Leo, E | 1 |
Amiraliev, MA; Barchuk, AS; Glagolev, AN; Grigoryeva, SP; Kovalev, VN; Malay, EF; Trakhtenberg, AKh; Vidyak, IV; Zakharchenkov, AV; Zhiglov, MA | 1 |
Gasparini, M; Roncoroni, I; Rottoli, L; Tondini, C | 1 |
Luini, A; Veronesi, U; Zucali, R | 1 |
Giuliano, AE; Morton, DL; Patterson, K; Sparks, FC; Spears, I | 1 |
Belpomme, D; Delgado, M; Fumoleau, P; Guerrin, J; Le Mevel, B; Mathé, G; Metz, R; Misset, JL; Plagne, R; Reizenstein, P | 1 |
Ragaz, J | 1 |
Jacobsen, AB; Kaalhus, O; Levernes, S; Melsom, H; Tausjø, J; Thorud, E; Thorvik, J; Vermund, H; Winther, F; Wist, E | 1 |
Dmitrieva, NV; Garin, AM; Lichintser, MR; Vyshinskaia, GV | 1 |
Biermann, WA; Cantor, RI; Schwartz, GF | 1 |
Haas, J; Jakse, R; Lehnert, M; Scherlacher, A | 1 |
Kaufmann, M; Michel, U; Schwarz, R | 1 |
Bonadonna, G; Tancini, G; Valagussa, P | 1 |
Possinger, K; Sauer, HJ; Wilmanns, W | 1 |
Gelber, RD; Goldhirsch, A | 1 |
Aplevich, NN; Gritsaĭ, AA; Kondrat'eva, AP; Lichinitser, MR; Vyshinskaia, GV | 1 |
Jakse, G; Schmid, KW | 1 |
Huntington, MO | 1 |
Airoldi, M; Camoletto, D; Fazio, M; Gandolfo, S; Negri, L; Ozzello, F; Pedani, F; Vercellino, V | 1 |
Lapukins, Z; Nitz, U; Rehwald, U; Sauerwein, W; Scherer, E; Schmitt, G | 1 |
Boidi Trotti, A | 1 |
Lee, YT | 2 |
Blumenschein, GR; Buzdar, AU; Fastenberg, NA; Hortobagyi, GN; Jessup, JM; Martin, RG; Montague, ED | 1 |
Oliver, RT | 1 |
Jakse, R; Lehnert, M; Scherlacher, A | 1 |
Johnson, JT; Mayernik, DG; Myers, EN; Nolan, TA; Schramm, VL; Sigler, BA; Srodes, CH; Wagner, RL | 1 |
Henderson, IC | 1 |
Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC | 1 |
Ferguson, DJ; Gaynor, ER; Golomb, HM; Griem, ML; Oleske, D; Ultmann, JE; Vokes, EE | 1 |
Hoshino, A; Ito, Y; Kamiya, O; Kinoshita, T; Kojima, T; Nagata, K; Ohara, K; Sato, H; Sugiura, I; Yamada, M | 1 |
Delgado, G; Edwards, BK; Marantz, AB; Posada, JG; Schein, PS; Smith, FP; Yeung, KY | 1 |
Herr, HW | 1 |
Endoh, F; Fujimoto, S; Kawata, S; Kurihara, M; Miyazaki, M; Ohta, M; Shimura, T; Sugasawa, H; Takahashi, O; Udagawa, I | 1 |
Iwanaga, T; Koyama, H; Sasaki, Y; Shiba, E; Terasawa, T; Wada, A | 1 |
Bavli, IaL; Migmanova, NSh; Moiseenko, VM; Rzhankov, SV; Semiglazov, VF | 1 |
Bachenheimer, L; Beiser, C; Byrne, P; Dritschilo, A; Goldberg, R; Smith, F; Smith, L; Stefanik, D; Ueno, W | 1 |
Kitahara, T; Konda, C; Minato, K; Nagai, M; Sakano, T; Shimoyama, M; Takenaka, T | 1 |
Anko, H; Arai, M; Ide, H; Kitamura, Y; Murata, Y; Ota, S; Suguro, M; Suzuki, S; Yamashita, Y; Yoshii, K | 1 |
Gödde, S; Vahlensieck, W | 1 |
Brought, J; Kithier, K; Lusher, J; Poulik, MD | 1 |
Southwick, HW | 1 |
Binder, S; Costanza, ME; Dayal, Y; Nathanson, L | 1 |
Livio, JJ; Pettavel, J | 1 |
Oberfield, RA | 1 |
Goldman, AL; Schwarz, MI; Whitcomb, ME | 1 |
Bloom, HJ; Freeman, JE; Hall, RR; Nawrocki, A; Wallace, DM | 1 |
Williams, RG | 1 |
Muckle, DS | 1 |
Galt, RM; Knock, FE; Oester, YT; Sylvester, R | 1 |
Goepfert, H; Jesse, RH; Lindberg, RD | 1 |
Swierzowa, J | 1 |
Schmidt, N; Schmidt-Hermes, HJ | 1 |
Dickson, JA; Muckle, DS | 1 |
Grigor, KM; Lewinsky, BS; Neville, AM; Symington, T | 1 |
Adachi, M; Fujimoto, S; Miyoshi, T; Urushibara, O; Watanabe, Y | 1 |
Thompson, V | 1 |
Leadbetter, WF; Skinner, DG | 1 |
Carey, RW; Graham, S; Holland, JF; Sheehe, PR | 1 |
Constable, WC; Fitz-Hugh, GS; Marks, RD; Robbins, JP | 1 |
Krishnamurthi, S; Sastri, DV; Shanta, V | 1 |
Alkek, DS; Urbach, F | 1 |
39 review(s) available for methotrexate and Lymph Node Metastasis
Article | Year |
---|---|
[Squamous cell carcinomas of the scrotum: about 7 cases with review of the literature].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Early Detection of Cancer; Genital Neoplasms, Male; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Plastic Surgery Procedures; Radiotherapy, Adjuvant; Scrotum; Skin Transplantation | 2015 |
[Plasmacytoid urothelial carcinoma of the bladder: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Diagnostic Imaging; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2009 |
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood-Testis Barrier; Bone Marrow; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Orchiectomy; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Testicular Neoplasms; Transplantation Conditioning; Treatment Failure; Vincristine | 2009 |
[Molecular subtypes and individualized treatment of breast cancer].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cetuximab; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Staging; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Trastuzumab | 2010 |
Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought.
Topics: Alendronate; Antineoplastic Protocols; Arthritis; Breast Neoplasms; Combined Modality Therapy; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Histiocytosis; Humans; Lymphatic Metastasis; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone | 2011 |
[Recent advance in adjuvant therapy for breast cancer].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tamoxifen; Tegafur; Uracil | 2002 |
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prospective Studies; Survival Rate; Treatment Outcome | 2003 |
[Radiation and concomitant chemotherapy after surgery for breast cancer].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors | 2004 |
[Sequencing of adjuvant treatment after surgery for invasive breast cancer].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hormones; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tamoxifen; Time Factors; Trastuzumab | 2004 |
Invasive ductal carcinoma within a fibroadenoma of the breast.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Female; Fibroadenoma; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Treatment Outcome | 2004 |
[Adjuvant chemotherapy based on evidence-based medicine for breast cancer patients].
Topics: Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Epirubicin; Evidence-Based Medicine; Female; Fluorouracil; Guidelines as Topic; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Meta-Analysis as Topic; Methotrexate; Receptor, ErbB-2; Taxoids; Trastuzumab | 2006 |
[Modern chemotherapy of invasive bladder cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Lymphatic Metastasis; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Paclitaxel; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2007 |
[Adjuvant chemotherapy in breast cancer: status in 1984].
Topics: Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Neoplasm Recurrence, Local; Time Factors | 1984 |
The role of post-operative radiotherapy in the treatment of operable breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Staging | 1984 |
[Adjuvant chemotherapy in breast cancer].
Topics: Antineoplastic Agents; Axilla; Breast Neoplasms; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Vincristine | 1981 |
The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
Topics: Axilla; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate | 1981 |
Choroidal infiltrates as the initial manifestation of lymphoma in rheumatoid arthritis after treatment with low-dose methotrexate.
Topics: Antigens, CD; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; Arthritis, Rheumatoid; Biopsy; Cell Adhesion Molecules; Cell Movement; Choroid Neoplasms; Diagnosis, Differential; Fatal Outcome; Female; Humans; Immunophenotyping; Lectins; Lymphatic Metastasis; Lymphoma, B-Cell; Methotrexate; Middle Aged; Ophthalmoscopy; Sialic Acid Binding Ig-like Lectin 2 | 1994 |
Adjuvant systemic therapy for breast cancer. Issues for primary care physicians.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Prognosis; Tamoxifen | 1995 |
Double modulation of 5-fluorouracil in the treatment of advanced colorectal carcinoma: report of a trial with sequential methotrexate, intravenous (loading dose) folinic acid, 5-fluorouracil, and a literature review.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Diarrhea; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome | 1994 |
Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Arterial infusion chemotherapy for peritoneal and liver metastasis in gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Stomach Neoplasms | 1997 |
[Benefits of adjuvant chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Mitomycin; Randomized Controlled Trials as Topic; Tamoxifen; Tegafur; Uracil | 1997 |
Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
Topics: Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Professional Staff Committees; Tamoxifen; Time Factors | 1998 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
[No advantage to using the CMF-regimen for node positive, postmenopausal, receptor-positive mammary carcinoma with adjuvant tamoxifen therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Prognosis; Randomized Controlled Trials as Topic; Tamoxifen | 1998 |
Phenotypic characterization of bladder cancer.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Disease Progression; Doxorubicin; Female; Humans; Immunotherapy; Lymphatic Metastasis; Male; Mass Screening; Methotrexate; Microscopy, Electron; Neoplasm Staging; Phenotype; Prognosis; Sensitivity and Specificity; Urinary Bladder Neoplasms; Vinblastine | 1998 |
[Adjuvant therapy of breast cancer].
Topics: Adult; Age Factors; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Goserelin; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Postoperative Care; Preoperative Care; Prognosis; Risk Factors; Tamoxifen | 2001 |
Adjuvant treatment in node-negative, postmenopausal breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Patient Care Planning; Postmenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Tamoxifen | 2001 |
The worldwide perspective in the adjuvant treatment of primary lymph node positive breast cancer.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; World Health Organization | 2001 |
Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Survival Rate | 2001 |
The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck.
Topics: Bleomycin; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Laryngeal Neoplasms; Leucovorin; Lip Neoplasms; Lymphatic Metastasis; Methotrexate; Mouth Neoplasms; Nasopharyngeal Neoplasms; Tongue Neoplasms | 1975 |
The integration of chemotherapy into combined modality treatment of solid tumors. VIII. Cervical cancer.
Topics: Alkylating Agents; Altretamine; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Radiotherapy, High-Energy; Radium; Uterine Cervical Neoplasms; Vaginal Smears | 1977 |
[The state of hormone and chemotherapy in breast neoplasms].
Topics: Androgens; Brain Neoplasms; Breast Neoplasms; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Estrogens; Female; Fluorouracil; Humans; Hypophysectomy; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Prednisone; Progesterone; Receptors, Cell Surface | 1978 |
[Hormone and chemotherapy of breast carcinoma].
Topics: Androgens; Breast Neoplasms; Castration; Cyclophosphamide; Drug Therapy, Combination; Estrogens; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Progestins | 1977 |
Evolving concepts in the systemic adjuvant treatment of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Prognosis; Tamoxifen | 1992 |
Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate | 1989 |
Patterns of metastasis and natural courses of breast carcinoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptors, Estrogen; Recurrence | 1985 |
The spectrum of diffuse pulmonary infiltration in malignant disease.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Busulfan; Embolism, Fat; Hemorrhage; Hodgkin Disease; Humans; Infusions, Parenteral; Leukemia; Lung Diseases; Lung Neoplasms; Lymphatic Metastasis; Lymphography; Lymphoma; Methotrexate; Pneumonia; Pneumonia, Pneumocystis; Radiation Injuries; Thyroid Neoplasms | 1973 |
239 trial(s) available for methotrexate and Lymph Node Metastasis
Article | Year |
---|---|
Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prospective Studies; Survival; Young Adult | 2014 |
Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate; Taiwan | 2015 |
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Endocrine System; Female; Fluorouracil; Humans; International Agencies; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause; Prognosis; Receptors, Estrogen; Survival Rate; Tamoxifen; Treatment Outcome | 2009 |
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Quality of Life; Risk Factors; Tegafur; Uracil | 2009 |
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Japan; Lymphatic Metastasis; Methotrexate; Middle Aged; Receptors, Estrogen; Survival Rate; Treatment Outcome; Young Adult | 2010 |
Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Tamoxifen; Tegafur; Uracil | 2009 |
Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidemiologic Methods; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause, Premature; Methotrexate; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome | 2010 |
Phase II trial of metronomic chemotherapy as salvage therapy for patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Prognosis; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Models, Biological; Proportional Hazards Models; Prospective Studies; Receptors, Estrogen; Treatment Outcome | 2011 |
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Receptors, Estrogen; Tamoxifen | 2011 |
Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cisplatin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitotic Index; Neoplasm Micrometastasis; Prognosis; Tamoxifen; Treatment Outcome | 2011 |
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Greece; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2012 |
Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Urinary Bladder Neoplasms | 2013 |
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Taxoids; Young Adult | 2013 |
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Lymphocytes, Tumor-Infiltrating; Methotrexate; Middle Aged; Predictive Value of Tests; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Taxoids; Treatment Outcome | 2013 |
Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Endocrine System; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Quality of Life; Tamoxifen; Time Factors; Treatment Outcome | 2002 |
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Logistic Models; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Multivariate Analysis; Prospective Studies; Vincristine | 2002 |
Pathologic changes related to CMF primary chemotherapy in breast cancer. Pathological evaluation of response predicts clinical outcome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Disease-Free Survival; Female; Fibrosis; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mammography; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Survival Rate | 2002 |
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Humans; Jews; Lymphatic Metastasis; Methotrexate; Mitoxantrone; Survival Analysis | 2002 |
Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Risk Factors; Survival Rate; Treatment Outcome | 2002 |
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Mastectomy, Radical; Melphalan; Menopause; Methotrexate; Middle Aged; Prednisone; Survival Rate; Vincristine | 2003 |
Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Urinary Bladder Neoplasms | 2002 |
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cause of Death; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Vincristine | 2003 |
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Vincristine | 2003 |
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prospective Studies; Survival Rate; Treatment Outcome | 2003 |
Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Goserelin; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Receptors, Estrogen; Risk Factors; Survival Analysis; Treatment Outcome | 2003 |
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Palliative Care; Prospective Studies; Survival Rate; Urologic Neoplasms; Vinblastine | 2003 |
[The modern organ- and function-sparing surgical treatment in oncology].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Electrosurgery; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fluorouracil; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Postoperative Care; Progestins; Prognosis; Prospective Studies; Radiotherapy Dosage; Risk Factors; Survival Analysis; Time Factors; Uterine Cervical Neoplasms | 2003 |
Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Climacteric; Cyclophosphamide; Factor Analysis, Statistical; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Quality of Life; Surveys and Questionnaires | 2003 |
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Goserelin; Humans; Incidence; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 2003 |
[Radiation and concomitant chemotherapy after surgery for breast cancer].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors | 2004 |
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphatic Metastasis; Mastectomy; Mastectomy, Segmental; Methotrexate; Middle Aged; Prospective Studies; Radiotherapy, Adjuvant; Recombinant Proteins; Risk Assessment; Risk Factors; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2004 |
1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Survival Rate; Tamoxifen | 2004 |
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized c
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Statistics, Nonparametric; Survival Analysis; Tamoxifen; Treatment Outcome | 2004 |
Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Proportional Hazards Models; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 2004 |
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; British Columbia; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Survival Analysis; Treatment Outcome | 2005 |
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Goserelin; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Tamoxifen | 2005 |
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Ca
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Postmenopause; Prognosis; Retrospective Studies | 2005 |
Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
Topics: Antineoplastic Agents; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Tamoxifen | 2005 |
A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Survival Analysis; Treatment Outcome | 2005 |
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2006 |
Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Axilla; Bayes Theorem; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Models, Biological; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Receptors, Estrogen | 2006 |
Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Paclitaxel; Prognosis | 2006 |
Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Paclitaxel; Survival Analysis | 2006 |
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Gene Amplification; Genes, erbB-2; Humans; Immunization, Passive; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Proteins; Neutropenia; Receptor, ErbB-2; Remission Induction; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Estrogen Receptor Modulators; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Postmenopause; Premenopause; Receptors, Estrogen; Survival Analysis; Tamoxifen | 2007 |
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Survival Rate; Tamoxifen | 2007 |
The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Colum
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Regression Analysis | 2007 |
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Tamoxifen | 2007 |
Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Germany; Humans; Leuprolide; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Perimenopause; Premenopause; Survival Rate; Treatment Outcome; Ukraine | 2007 |
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.
Topics: Adult; Age Factors; Anemia; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hemoglobins; Humans; Incidence; Leukocytes; Lymphatic Metastasis; Methotrexate; Middle Aged; Regression Analysis; Risk Factors; Severity of Illness Index; Time Factors | 2008 |
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Topics: Adult; Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Estrogens; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Paclitaxel; Peripheral Nervous System Diseases; Tamoxifen | 2008 |
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Odds Ratio; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Taxoids; Treatment Outcome | 2008 |
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Premenopause; Retrospective Studies; Treatment Outcome | 2008 |
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Survival Rate | 2008 |
Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Random Allocation; Tamoxifen | 1984 |
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone | 1984 |
The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mathematics; Methotrexate; Middle Aged; Prognosis; Regression Analysis; Retrospective Studies; Time Factors | 1983 |
A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Nausea; Paresthesia; Prednisone; Random Allocation; Time Factors; Vincristine; Vomiting | 1983 |
Adjuvant chemotherapy in stage-II breast cancer: an overview of the NSABP clinical trials.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Methotrexate; Middle Aged | 1983 |
Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Tamoxifen | 1983 |
Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Prednisone; Vincristine | 1983 |
Adjuvant therapy of breast cancer: the Southwest Oncology Group experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Vincristine | 1983 |
Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: the Southeastern Cancer Study Group experience.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate | 1983 |
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year results.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Prospective Studies; Receptors, Estrogen; Tamoxifen | 1983 |
Breast cancer 1984: state of the art.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Prednisone; Vincristine | 1984 |
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Prednisone; Prognosis; Tamoxifen | 1984 |
Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Radiotherapy Dosage; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Mastectomy; Methotrexate; Mitomycins; Neoplasm Staging; Prognosis; Vinblastine; Vincristine | 1984 |
The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Vincristine | 1984 |
Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1984 |
Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Vincristine | 1984 |
Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis | 1984 |
Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prednisone; Prognosis; Tamoxifen; Vincristine | 1984 |
Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prognosis; Radiotherapy Dosage; Receptors, Estrogen; Tamoxifen | 1984 |
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis | 1984 |
Southeastern Cancer Study Group: breast cancer studies 1972-1982.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Postoperative Care; Prednisone; Time Factors; United States; Vincristine | 1983 |
[Value of polychemotherapy in the treatment of children with neuroblastoma].
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Methotrexate; Neuroblastoma; Prednisolone; Retroperitoneal Neoplasms; Vincristine | 1981 |
A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Prospective Studies; Radiotherapy Dosage; Random Allocation | 1981 |
[The results of 5 years of ancillary chemotherapy of carcinoma of the breast (author's transl)].
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Postoperative Care; Vinblastine | 1981 |
The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
Topics: Axilla; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate | 1981 |
Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
Topics: BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Random Allocation | 1980 |
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
Topics: Aged; Amenorrhea; Axilla; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prognosis | 1981 |
Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate | 1982 |
Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.
Topics: Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Lymphatic Metastasis; Menopause; Methotrexate; Mycobacterium bovis | 1982 |
Favorable factors in the adjuvant therapy of breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1982 |
Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Vincristine | 1982 |
[About the value of adjuvant chemotherapy in advanced cervical cancer. First results of a prospective randomised study (author's transl)].
Topics: Cervix Uteri; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Random Allocation; Uterine Cervical Neoplasms; Vincristine | 1982 |
[Dose intensity in M-VAC chemotherapy with rG-CSF for metastatic transitional urothelial cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 1994 |
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Recombinant Proteins; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization | 1994 |
[Intraperitoneal infusion therapy of MTX and 5-FU for advanced gastric cancer and its peritoneal metastasis].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Lymphatic Metastasis; Methotrexate; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms | 1995 |
Randomized cooperative study of perioperative chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Italy; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Multivariate Analysis; Postmenopause; Receptors, Estrogen; Survival Rate; Tamoxifen | 1995 |
[Clinical efficacy of methotrexate, vinblastine, doxorubicin and cisplatin adjuvant chemotherapy following radical surgery for locally invasive urothelial cancers: long-term results].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Postoperative Care; Prognosis; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1995 |
[A randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Randomized Controlled Trials as Topic; Tamoxifen | 1995 |
[Lymphatic interventional radiology in the treatment of lymphatic neoplasmas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphatic Metastasis; Lymphography; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radiography, Interventional; Stomach Neoplasms; Thiotepa | 1995 |
[The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Design and rationale of a randomised comparison of cyclophosphamide, methotrexate and fluorouracil vs fluorouracil, epirubicin and cyclophosphamide in node-positive premenopausal women with operable breast cancer. A trial of the International Collaborativ
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause | 1993 |
Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Analysis; Urinary Bladder Neoplasms; Vincristine | 1993 |
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Prednisone; Proportional Hazards Models; Receptors, Estrogen; Survival Rate; United States; Vincristine | 1995 |
Ten-year results of a randomized trial evaluating prolonged low-dose adjuvant chemotherapy in node-positive breast cancer: a joint European Organization for Research and Treatment of Cancer-Dutch Breast Cancer Working Party Study. Cooperating Investigator
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies | 1995 |
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Ovariectomy; Postmenopause; Prednisone; Premenopause; Survival Rate; Switzerland; Tamoxifen | 1994 |
Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prospective Studies; Regression Analysis; Survival Analysis | 1995 |
Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Postoperative Care; Radiotherapy Dosage; Recurrence; Retrospective Studies; Time Factors | 1995 |
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Radical; Methotrexate; Middle Aged; Regression Analysis; Treatment Outcome | 1995 |
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Germany; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Multivariate Analysis; Patient Compliance; Regression Analysis; Survival Rate; Tamoxifen | 1994 |
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Prednisone; Proportional Hazards Models; Receptors, Estrogen; Tamoxifen; United States; Vincristine | 1994 |
[Pathomorphosis of metastatic malignant melanoma of the skin as effected by preoperative endolymphatic polychemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Humans; Injections, Intralymphatic; Lymphatic Metastasis; Melanoma; Methotrexate; Middle Aged; Preoperative Care; Prospidium; Skin Neoplasms; Survival Rate; Time Factors; Treatment Outcome | 1993 |
[Prevention and treatment of regional lymphatic metastasis of cutaneous melanoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Injections, Intralymphatic; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Methotrexate; Neoplasm Staging; Preoperative Care; Prospidium; Skin Neoplasms; Survival Rate | 1993 |
Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prospective Studies; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1995 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Costa Rica; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Infusions, Intravenous; Leucovorin; Life Tables; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1994 |
Double modulation of 5-fluorouracil in the treatment of advanced colorectal carcinoma: report of a trial with sequential methotrexate, intravenous (loading dose) folinic acid, 5-fluorouracil, and a literature review.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Diarrhea; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome | 1994 |
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prednisone; Proportional Hazards Models; Receptors, Estrogen; Survival Analysis; Time Factors; Vincristine | 1993 |
Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prospective Studies; Tamoxifen | 1993 |
Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Proportional Hazards Models | 1993 |
A preliminary report of a pilot randomized trial comparing cyclophosphamide, methotrexate and 5-fluorouracil with cyclophosphamide, mitoxantrone and 5-fluorouracil in the adjuvant therapy of stage II breast cancer with four or more positive axillary nodes
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leukocyte Count; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Prospective Studies | 1993 |
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Rate; Tamoxifen; Thiotepa; Vinblastine | 1993 |
Adjuvant six cycles of high-dose adriamycin, cyclophosphamide, methotrexate, 5-fluorouracil (ACMF) vs. 12 cycles of low-dose ACMF with tamoxifen for premenopausal, node-positive breast cancer patients: results of a prospective randomized study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prospective Studies; Survival Rate; Tamoxifen | 1995 |
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collab
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Nausea; Premenopause; Regression Analysis; Survival Analysis; Vomiting | 1996 |
Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distribution; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Ovariectomy; Prednisone; Premenopause; Proportional Hazards Models; Receptors, Estrogen; Survival Rate; Vincristine | 1996 |
Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Europe; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Premenopause | 1996 |
A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome | 1996 |
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; France; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Postmenopause; Premenopause; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Premenopause; Treatment Failure | 1996 |
Simultaneous radiochemotherapy for recurrent and metastatic breast carcinoma: evaluation of two treatment concepts.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Mitomycin; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Radiotherapy; Remission Induction | 1996 |
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of finding
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Receptors, Estrogen; Survival Rate | 1996 |
Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Time Factors | 1996 |
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Radiotherapy, Adjuvant; Receptors, Estrogen; Survival Analysis; Survival Rate; Tamoxifen | 1996 |
Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Sensitivity and Specificity; Survival Rate | 1996 |
[Sequencing of chemotherapy and radiotherapy following breast-preserving treatment of breast carcinoma].
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate; Prednisone; Prognosis; Prospective Studies; Radiotherapy Dosage; Time Factors | 1996 |
Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Pilot Projects; Survival Rate; Thymidine Phosphorylase; Treatment Outcome | 1997 |
Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Survival Rate; Uterine Cervical Neoplasms | 1997 |
Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Tamoxifen; Treatment Failure; Treatment Outcome | 1997 |
Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chlorambucil; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Switzerland; Treatment Outcome | 1997 |
Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; False Negative Reactions; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Radical; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Ductal, Lobular, and Medullary; Prognosis; Sensitivity and Specificity; Tamoxifen | 1997 |
[Endoscopic local injection of anticancer drugs bound to carbon particles for treatment of upper digestive tract cancers--clinical trials].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carbon; Carcinoma, Squamous Cell; Endoscopy, Digestive System; Esophageal Neoplasms; Humans; Injections, Intralesional; Lymphatic Metastasis; Methotrexate; Peplomycin; Prognosis; Stomach Neoplasms; Treatment Outcome | 1997 |
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Estrogen Antagonists; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Risk; Survival Analysis; Tamoxifen; Treatment Failure; Treatment Outcome | 1997 |
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Premenopause; Proportional Hazards Models; Survival Analysis | 1997 |
Lack of effectiveness of adjuvant alternating chemotherapy in node-positive, estrogen-receptor-negative premenopausal breast cancer patients: results of a multicentric Italian study. The Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group (GROC
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Premenopause; Receptors, Estrogen; Survival Analysis; Vincristine; Vindesine | 1997 |
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Tumor Suppressor Protein p53 | 1998 |
[Sequential chemotherapy with methotrexate and 5-fluorouracil for advanced gastric cancer].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorouracil; Humans; Injections, Intravenous; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Stomach Neoplasms | 1998 |
Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Contrast Media; Doxorubicin; Female; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Sensitivity and Specificity; Treatment Failure; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Quality of Life; Surveys and Questionnaires; Survival Analysis; Treatment Outcome | 1998 |
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Survival Rate | 1998 |
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
Topics: Adult; Age Distribution; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause | 1998 |
Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Osteosarcoma; Time Factors | 1998 |
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Regression Analysis; Survival Rate; Vincristine | 1999 |
Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodes.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Female; Fluorouracil; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Survival Analysis | 1999 |
Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Predictive Value of Tests; Receptor, ErbB-2; Receptors, Estrogen; Regression Analysis; Survival Rate; Time Factors | 1999 |
Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Monitoring; Female; Fluorouracil; Follow-Up Studies; Humans; Leukocyte Count; Leukopenia; Life Tables; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Receptors, Progesterone; Survival Rate; Time Factors | 1999 |
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prognosis; Quinazolines; Survival Rate; Thiophenes; Treatment Outcome | 1999 |
High dose chemotherapy for refractory urothelial carcinoma supported by peripheral blood stem cell transplantation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Urologic Neoplasms; Vinblastine | 1999 |
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Rate; Tamoxifen; Vincristine | 1999 |
Adjuvant chemotherapy with a combination of mitoxantrone, methotrexate, 5-fluorouracil for node-positive breast cancer: phase II pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Child; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitoxantrone | 1999 |
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Premenopause; Tamoxifen | 1999 |
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome | 2000 |
[Dose intensified adjuvant chemotherapy in high risk breast carcinoma with 4-9 positive lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Staging; Prospective Studies | 2000 |
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Italy; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitotic Index; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Prospective Studies; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 2000 |
[Randomized comparative study of CMF (cyclophosphamide, methotrexate and 5-fluorouracil) and UFT-tamoxifen regimens as adjuvant chemotherapy after surgery for breast cancer: Tochigi Prefectural Study Group for Post-Breast Cancer Adjuvant Chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Survival Rate; Tamoxifen; Tegafur; Uracil | 2000 |
Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Quality of Life; Surveys and Questionnaires; Survivors; Time Factors | 2000 |
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Patient Compliance; Prospective Studies; Risk Factors | 2000 |
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Patient Compliance; Placebos; Receptors, Estrogen; Survival Analysis; Tamoxifen | 2001 |
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Immunohistochemistry; Lymphatic Metastasis; Mastectomy, Radical; Methotrexate; Middle Aged; Proportional Hazards Models; Prospective Studies; Receptor, ErbB-2; Survival Analysis | 2001 |
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Flow Cytometry; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Medical Futility; Methotrexate; Multivariate Analysis; Predictive Value of Tests; Prednisone; Proportional Hazards Models; Reproducibility of Results; S Phase; Survival Rate | 2001 |
Intra-arterial plus i.v. chemotherapy for advanced bulky squamous cell carcinoma of the buccal mucosa.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Eruptions; Dyspnea; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Stomatitis; Survival Rate; Treatment Outcome | 2001 |
Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF.
Topics: Adult; Age Distribution; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis | 2001 |
[Cisplatin and vinorelbine therapy of previously treated advanced breast cancer (preliminary studies)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Skin Neoplasms; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Staging; Survival Analysis | 2001 |
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Routes; Drug Synergism; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Survival Rate; Treatment Outcome | 2002 |
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative dos
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Belgium; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Premenopause | 2002 |
Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the cervix.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Methotrexate; Remission, Spontaneous; Uterine Cervical Neoplasms; Vincristine | 1976 |
Treatment of early breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Postoperative Care; Prednisone; Time Factors; Vincristine | 1978 |
Combination chemotherapy in the management of superior vena caval obstruction in small-cell anaplastic carcinoma of the lung.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Vascular Diseases; Vena Cava, Superior; Vincristine | 1978 |
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
Topics: Amenorrhea; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Thrombocytopenia | 1977 |
Adjuvant chemotherapy in the primary management of breast cancer.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Survival; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Recurrence; Research Design | 1977 |
Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Recurrence | 1977 |
Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Time Factors | 1977 |
Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.
Topics: Administration, Oral; Aged; BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Neoplasm Recurrence, Local | 1978 |
[Combined drug treatment of far-advanced forms of breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Castration; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Hexestrol; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Neoplasm Metastasis; Prednisolone; Testosterone; Time Factors; Vincristine | 1978 |
Pilot study on adjuvant chemotherapy and hormonal therapy for irradiated inoperable breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Pilot Projects; Tamoxifen; Vincristine | 1978 |
Combination chemotherapy in advanced postmenopausal mammary carcinoma. A comparison between VAC and VACM therapy.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Random Allocation; Vincristine | 1979 |
Immunology and adjuvant chemoimmunotherapy of breast cancer.
Topics: Aged; Animals; Antibodies, Neoplasm; BCG Vaccine; Breast Neoplasms; Carcinoma; Chick Embryo; Cyclophosphamide; Female; Fluorouracil; Humans; Immunotherapy; Lymphatic Metastasis; Male; Melanoma; Methotrexate; Middle Aged; Prospective Studies; Sarcoma | 1976 |
[Chemotherapy of metastasizing breast cancers. Indications and results].
Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Prednisone; Remission, Spontaneous; Thoracic Neoplasms; Time Factors; Vincristine | 1975 |
[Neoadjuvant chemotherapy in combined treatment of breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Prospective Studies; Radiotherapy Dosage; Remission Induction; Thiotepa | 1992 |
Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Survival Analysis | 1992 |
Factors affecting the outcome of patients with advanced urothelial cancer following chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Regression Analysis; Survival Rate; Treatment Outcome; Urologic Neoplasms; Vinblastine | 1992 |
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Proteins; Receptors, Estrogen; Tamoxifen | 1992 |
Swiss adjuvant trials in women with node-negative breast cancer. OSAKO.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Chemotherapy, Adjuvant; Chlorambucil; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Risk Factors; Switzerland | 1992 |
Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Patient Compliance; Prospective Studies; Receptors, Estrogen; Risk Factors; Survival Rate | 1992 |
West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chlorambucil; England; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Odds Ratio; Prognosis; Risk Factors; Survival Rate | 1992 |
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Neoplasm Recurrence, Local; Postoperative Care; Prednisone; Receptors, Estrogen; Risk Factors; Survival Rate | 1992 |
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycin; Skin Neoplasms; Time Factors | 1992 |
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Tamoxifen; Vincristine | 1992 |
A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Melphalan; Methotrexate; Middle Aged; Survival Rate | 1991 |
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Heart Failure; Humans; Infusions, Intravenous; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Survival Analysis | 1991 |
A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines | 1991 |
Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphatic Metastasis; Methotrexate; Middle Aged; Patient Compliance | 1991 |
Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the Hoosier Oncology Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Drug Evaluation; Female; Hematologic Diseases; Humans; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Stomatitis; Survival Rate; Vinblastine | 1991 |
Late effects of adjuvant oophorectomy and chemotherapy upon premenopausal breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Ovariectomy; Prednisone; Receptors, Estrogen | 1990 |
[Stage T4 bladder cancer. Impact of neoadjuvant chemotherapy on T4b tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Rate; Urinary Bladder Neoplasms; Urinary Diversion; Vinblastine | 1990 |
Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cyclophosphamide; DNA, Neoplasm; Female; Flow Cytometry; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Menopause; Methotrexate; Prognosis; S Phase | 1990 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Survival Analysis; Tamoxifen | 1990 |
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Italy; Lymph Nodes; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Prospective Studies; Random Allocation; Receptors, Estrogen; Tamoxifen | 1990 |
[Induction chemotherapy in ORL oncology. Apropos of 39 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Humans; Lymphatic Metastasis; Methotrexate; Otorhinolaryngologic Neoplasms; Time Factors; Vincristine | 1986 |
[Chemotherapy of advanced head and neck tumors. A prospective randomized study comparing the effectiveness of chemotherapy alone to a chemo-radiotherapy procedure].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Random Allocation | 1987 |
Prospective computerized simulation of breast cancer: comparison of computer predictions with nine sets of biological and clinical data.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Computer Simulation; Cyclophosphamide; DNA, Neoplasm; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neovascularization, Pathologic | 1987 |
Chemotherapy plus adjuvant surgery for local small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pneumonectomy; Preoperative Care; Remission Induction; Vincristine | 1989 |
Prolonged adjuvant chemotherapy in breast cancer. The Scandinavian Adjuvant Chemotherapy Study 2.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Immunotherapy; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Vincristine | 1989 |
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Postoperative Care; Random Allocation; Receptors, Estrogen; Receptors, Progesterone | 1989 |
Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Random Allocation; Receptors, Estrogen | 1989 |
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Mastectomy, Radical; Melphalan; Methotrexate; Prednisone; Vincristine | 1989 |
[M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1989 |
Randomized multicenter 2 x 2-factorial design study of chemo/endocrine therapy in operable, node-positive breast cancer (protocol 2).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Evaluation Studies as Topic; Fluorouracil; Germany, West; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Multicenter Studies as Topic; Physician's Role; Randomized Controlled Trials as Topic; Research Design; Tamoxifen | 1989 |
Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Chlorambucil; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged | 1989 |
Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menstruation; Methotrexate; Middle Aged; Prednisone; Receptors, Progesterone; Risk | 1985 |
A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menstruation; Methotrexate; Middle Aged; Ovary; Prednisone; Random Allocation | 1985 |
Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Preoperative Care; Random Allocation; Tamoxifen | 1988 |
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Follow-Up Studies; Humans; Italy; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Prognosis; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1988 |
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Radical; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Random Allocation; Receptors, Estrogen; Risk Factors | 1989 |
Performance of general hospitals in delivering adjuvant chemotherapy to breast cancer patients. G.I.V.I.O. (Interdisciplinary Group for Cancer Care Evaluation), Italy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Delivery of Health Care; Female; Fluorouracil; Hospitals, General; Humans; Italy; Lymphatic Metastasis; Menopause; Methotrexate; Multicenter Studies as Topic; Prospective Studies | 1988 |
Tolerance of radiotherapy combined with adjuvant chemotherapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Pulmonary Fibrosis; Radiotherapy, High-Energy; Random Allocation | 1987 |
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Prospective Studies; Receptors, Estrogen; Time Factors | 1988 |
Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Information Systems; Lymphatic Metastasis; Medical Records; Melphalan; Methotrexate; Middle Aged; Postoperative Care; Prednisone; Random Allocation; Time Factors; Vincristine | 1987 |
Development and use of a natural history data base of breast cancer studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Information Systems; Lymphatic Metastasis; Mastectomy; Medical Records; Methotrexate; Middle Aged; Postoperative Care; Prognosis; Time Factors | 1987 |
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Menstrual Cycle; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Prospective Studies; Random Allocation; Receptors, Estrogen; Time Factors | 1987 |
Combined treatment including postoperative chemotherapy in lung cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Random Allocation; Statistics as Topic | 1988 |
Local control and survival in early breast cancer: the Milan trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Italy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Random Allocation; Time Factors | 1986 |
Adjuvant chemo-immunotherapy in stage II carcinoma of the breast.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Cell Line; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Hepatitis B; Humans; Immunotherapy; Lymphatic Metastasis; Methotrexate; Middle Aged; Research Design; Vaccines | 1986 |
Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Random Allocation; Vincristine | 1986 |
Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Methotrexate; Middle Aged; Receptors, Estrogen; Tamoxifen | 1986 |
Preoperative (neoadjuvant) chemotherapy for breast cancer: outline of the British Columbia Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cell Division; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Random Allocation; Receptors, Estrogen | 1986 |
Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Switzerland | 1986 |
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Quality of Life; Statistics as Topic; Tamoxifen | 1986 |
Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Prednisone; Prognosis; Tamoxifen; Vincristine | 1985 |
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Obesity; Prednisone; Prognosis; Random Allocation; Receptors, Estrogen; Risk; Tamoxifen | 1985 |
The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisolone; Vincristine | 1985 |
Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy.
Topics: Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Postoperative Care; Preoperative Care; Radiotherapy, High-Energy; Time Factors; Urinary Bladder Neoplasms | 1985 |
Studies on preoperative cancer chemotherapy. Effects of preoperative intra-arterial infusion of methotrexate and mitomycin C on stomach cancer.
Topics: Adult; Aged; Biopsy; Clinical Trials as Topic; Culture Techniques; Female; Humans; Injections, Intra-Arterial; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mitomycins; Peptic Ulcer; Pyridoxal Phosphate; Stomach Neoplasms; Thymidine; Tritium | 1971 |
351 other study(ies) available for methotrexate and Lymph Node Metastasis
Article | Year |
---|---|
Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2021 |
Morphological Study of Mesenteric Lymph Nodes in Rats with Experimental Breast Cancer Treated with Fragmented Double-Stranded DNA.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; DNA; DNA Fragmentation; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mastectomy; Mesentery; Methotrexate; Methylnitrosourea; Rats; Rats, Wistar; Treatment Outcome | 2020 |
Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Survival Rate; Urologic Neoplasms | 2017 |
[
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Urinary Bladder Neoplasms; Vinblastine | 2017 |
Anterior Mediastinal Lymph Nodes in Chemically Induced Breast Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Cell Proliferation; Cyclophosphamide; Female; Fluorouracil; Injections, Subcutaneous; Lymph Nodes; Lymphatic Metastasis; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mediastinum; Methotrexate; Methylnitrosourea; Plasma Cells; Rats; Rats, Wistar; T-Lymphocytes | 2017 |
Glycolysis Inhibitors Monoiodoacetate and 2-Deoxyglucose as Antitumor Agents: Experimental Study on Lewis Lung Carcinoma Model.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Deoxyglucose; Glycolysis; Iodoacetic Acid; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Mice; Mice, Inbred C57BL; Treatment Outcome; Tumor Burden | 2018 |
Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Survival Rate; Taxoids | 2013 |
Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2013 |
Failure and success in the treatment of breast carcinoma in men: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Fluorouracil; Fractures, Compression; Humans; Kyphoplasty; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Spinal Fractures; Spinal Neoplasms; Stents; Tamoxifen; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Vertebroplasty | 2014 |
Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Triple Negative Breast Neoplasms | 2014 |
[A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adjuvant chemotherapy in patients with node-negative, triple-negative breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Tegafur; Triple Negative Breast Neoplasms; Uracil | 2014 |
[Adenoid cystic carcinoma of the breast:report of 25 cases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Adenoid Cystic; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy; Methotrexate; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2014 |
Neoadjuvant therapy combined with a BMP regimen for treating penile cancer patients with lymph node metastasis: a retrospective study in China.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; China; Cisplatin; Drug Administration Schedule; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Medical Records; Methotrexate; Middle Aged; Neoadjuvant Therapy; Palliative Care; Penile Neoplasms; Retrospective Studies; Treatment Failure; Treatment Outcome | 2014 |
Intraarterial chemotherapy as the first-line therapy in penile cancer.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Fluorouracil; Humans; Infusions, Intra-Arterial; Inguinal Canal; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Penile Neoplasms; Retrospective Studies | 2014 |
Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities.
Topics: 4-Nitroquinoline-1-oxide; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Carcinoma, Squamous Cell; Down-Regulation; Doxorubicin; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mouth Neoplasms; Nanoparticles; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor C | 2014 |
Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Mammaplasty; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Retrospective Studies; Survival Rate | 2014 |
Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Survival Rate; Time Factors | 2014 |
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium; Vinblastine | 2015 |
Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Epirubicin; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Methotrexate; Neoadjuvant Therapy; Risk Assessment; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 2016 |
The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Urologic Neoplasms; Vinblastine | 2015 |
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Azacitidine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Estrogen Receptor alpha; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Methotrexate; Organ Specificity; Promoter Regions, Genetic; Purine-Nucleoside Phosphorylase; Receptor, ErbB-2; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; Triple Negative Breast Neoplasms | 2016 |
Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; France; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2017 |
Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Remission Induction; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 2009 |
Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Taxoids | 2008 |
The prognostic impact of occult nodal metastasis in early breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Bone Marrow; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Norway; Prognosis; Tamoxifen | 2009 |
Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study.
Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Retrospective Studies; Tissue Inhibitor of Metalloproteinase-1; Treatment Outcome | 2009 |
Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2009 |
[Clinical impact of extracapsular extension of axillary lymph node metastases in breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Postmenopause; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Rate | 2009 |
Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Choroid Neoplasms; Dactinomycin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2010 |
Comparison of three adjuvant chemotherapy regimes using an extended log-logistic model in women with operable breast cancer.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Iran; Lymphatic Metastasis; Methotrexate; Middle Aged; Models, Statistical; Neoplasm Staging; Prognosis; Survival Rate; Taxoids | 2010 |
Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Multivariate Analysis; Regression Analysis; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden; Urinary Bladder Neoplasms; Vinblastine | 2010 |
Metronomic cyclophosphamide and methotrexate for breast cancer: enhanced efficacy by adding dalteparin and low-dose prednisone?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dalteparin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Prednisone; Tomography, X-Ray Computed | 2011 |
Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Multivariate Analysis; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium | 2012 |
Durable complete response induced by paclitaxel-nimotuzumab-methotrexate chemotherapy in a patient with metastatic head and neck squamous cell carcinoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Multimodal Imaging; Paclitaxel; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Carboplatin; Confidence Intervals; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Female; Fluorouracil; Gemcitabine; Health Services Accessibility; Humans; Logistic Models; Lymphatic Metastasis; Medication Adherence; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Paclitaxel; Receptors, Estrogen; Switzerland; Taxoids; Vinblastine; Vinorelbine | 2012 |
[A case of primary urotherial carcinoma with glandular differentiation of the renal pelvis with high serum level of carbohydrate antigen 19-9 (CA19-9)].
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Carcinoma; Cisplatin; Doxorubicin; Humans; Kidney Neoplasms; Kidney Pelvis; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Urothelium; Vinblastine | 2012 |
FDG-PET guided diagnosis of vaginal intravascular diffuse large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capillaries; Cyclophosphamide; Fatal Outcome; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Paraproteins; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Vagina; Vascular Neoplasms; Vincristine | 2012 |
Clinicopathological significance of mesothelin expression in invasive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; GPI-Linked Proteins; Humans; Immunohistochemistry; Lymphatic Metastasis; Mesothelin; Methotrexate; Neoplasm Invasiveness; Paraffin Embedding; Radiotherapy; Receptor, ErbB-3; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2012 |
A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Nephrectomy; Retrospective Studies; Survival Analysis; Ureter; Ureteral Neoplasms; Vinblastine | 2012 |
[Mycosis fungoides palmaris et plantaris].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; CD3 Complex; CD8-Positive T-Lymphocytes; Chemotherapy, Adjuvant; Combined Modality Therapy; Diagnosis, Differential; Electrons; Foot Dermatoses; Hand Dermatoses; Humans; Lymphatic Metastasis; Male; Methotrexate; Mycosis Fungoides; Skin; Skin Neoplasms; T-Lymphocytes | 2012 |
[Breast carcinoma in accessory gland: a case report].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Methotrexate; Middle Aged; Tamoxifen; Time Factors | 2002 |
A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Survivors | 2002 |
Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystectomy; Doxorubicin; Epirubicin; Evidence-Based Medicine; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 2002 |
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Goserelin; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Receptors, Estrogen | 2002 |
The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Cystectomy; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Pelvis; Prognosis; Retrospective Studies; Urinary Bladder Neoplasms | 2003 |
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Belgium; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Leukemia, Myeloid; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Retrospective Studies | 2003 |
Adjuvant chemotherapy in breast cancer: back to the future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Staging; Randomized Controlled Trials as Topic; Vincristine | 2003 |
S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Forecasting; Humans; Japan; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pyridines; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome | 2003 |
[A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Pancreatic Neoplasms; Stomach Neoplasms; Tegafur | 2003 |
[Atypical Guerin T8 epithelioma in the white rat].
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Carcinoma; Immunity; Lymphatic Metastasis; Methotrexate; Neoplasms; Neoplasms, Experimental; Radiation Effects; Rats | 1963 |
[APROPOS OF THE TREATMENT OF TUMORS OF THE TESTICLE].
Topics: Castration; Choriocarcinoma; Dactinomycin; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mechlorethamine; Methotrexate; Neoplasms; Pregnancy; Teratoma; Testicular Neoplasms | 1963 |
THE INTRALYMPHATIC ADMINISTRATION OF RADIOACTIVE ISOTOPES AND CANCER CHEMOTHERAPEUTIC DRUGS.
Topics: Abdominal Neoplasms; Angiography; Breast Neoplasms; Geriatrics; Gold; Humans; Injections; Iodine Isotopes; Leukemia; Lymphatic Metastasis; Lymphatic System; Lymphography; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Melphalan; Methotrexate; Neoplasms; Radioisotopes; Radionuclide Imaging; Retroperitoneal Neoplasms; Scandium; Thiotepa; Yttrium | 1964 |
THE USE OF CHEMOTHERAPEUTIC AGENTS IN THE TREATMENT OF CHILDHOOD CANCER.
Topics: Adrenal Cortex Hormones; Antimetabolites; Antineoplastic Agents; Child; Hodgkin Disease; Humans; Infant; Leukemia; Lymphatic Metastasis; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Nitrogen Mustard Compounds; Toxicology; Vincristine | 1964 |
REGIONAL ARTERIAL INFUSION OF ANTIMETABOLITES. AN ANALYSIS OF THE RESULTS OBTAINED IN 33 PATIENTS WITH MALIGNANT TUMORS OF THE HEAD AND NECK.
Topics: Antimetabolites; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Injections, Intra-Arterial; Lymphatic Metastasis; Lymphoma; Maxillary Neoplasms; Methotrexate; Mouth Neoplasms; Neoplasms; Nose Neoplasms; Parotid Neoplasms; Pharyngeal Neoplasms; Skin Neoplasms | 1965 |
[Therapy of advanced penis carcinoma].
Topics: Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Graft Survival; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Microsurgery; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Penile Neoplasms; Skin; Superinfection; Surgical Flaps; Surgical Wound Infection; Suture Techniques; Treatment Outcome; Wound Healing | 2003 |
[A case of advanced gastric cancer that responded to docetaxel with low-dose 5-FU and cisplatin combination chemotherapy after becoming chemoresistant to M-FLP].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Taxoids | 2003 |
Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Guideline Adherence; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Medical Audit; Methotrexate; Middle Aged; Practice Guidelines as Topic; Retrospective Studies | 2004 |
Using loco-regional recurrence as an indicator of the quality of breast cancer treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2004 |
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Life Tables; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Paclitaxel; Prednisone; Prognosis; Receptors, Progesterone; Risk; Survival Analysis; Tamoxifen; Taxoids; Transcription Factors; Vincristine | 2004 |
[Multiple metastases of the penile cancer: an experience of combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplastic Cells, Circulating; Penile Neoplasms; Penis | 2004 |
[A case of curatively resected gastric cancer through an effective response to chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Jejunostomy; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Pancreatic Neoplasms; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms | 2004 |
Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Guideline Adherence; Guidelines as Topic; Humans; Lymphatic Metastasis; Medical Oncology; Methotrexate; Middle Aged; Quality Assurance, Health Care; Radiotherapy; Retrospective Studies; Survival Analysis | 2004 |
[Clinical study of modified M-VAC therapy with one 21-day cycle for advanced urothelial cancer].
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neutropenia; Thrombocytopenia; Urologic Neoplasms; Vinblastine | 2004 |
Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Odds Ratio; Prognosis; Receptors, Estrogen; Survival Analysis | 2004 |
Chemoresistant placental site trophoblastic tumor with hilar lymph node metastasis: an unusual site of involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphatic Metastasis; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Vincristine | 2005 |
Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Premenopause; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2005 |
[A patient with metastatic breast cancer associated with retention of pleural effusion with no response to both CMF and exemestane, whose life was saved by high-dose toremifene].
Topics: Aged; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Pleural Effusion; Remission Induction; Salvage Therapy; Toremifene | 2005 |
[Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Mastectomy; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate | 2005 |
[Two cases of urothelial cancer responsive to high-dose-intensity methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Staging; Pulse Therapy, Drug; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2005 |
[Minutes of the 23th meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO). Amsterdam, 24-28 October 2004].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amifostine; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Mastectomy; Methotrexate; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation-Protective Agents; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Rectal Neoplasms; Time Factors | 2005 |
Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Decision Trees; Doxorubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 2005 |
[A case of head and neck squamous cell carcinoma suffering from acute renal failure after methotrexate administrator].
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged | 2005 |
[Personal experiences with methotrexate in tumor therapy].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Treatment Outcome | 1966 |
[Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate; Oxonic Acid; Palliative Care; Pyridines; Stomach Neoplasms; Tegafur | 2005 |
Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasms, Ductal, Lobular, and Medullary; Prognosis; Prospective Studies; Receptors, Estrogen; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combinations; Floxuridine; Fluorouracil; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Neoplasm Staging; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 2005 |
Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies | 2006 |
Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Breast; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Dose Fractionation, Radiation; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Risk Factors; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Staging; Receptors, Steroid; Tamoxifen | 2006 |
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cisplatin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Linear Models; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycins; Neoplasm Proteins; Neoplasm Recurrence, Local; Odds Ratio; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Risk Factors; Secondary Prevention; Tamoxifen | 2006 |
A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; SEER Program | 2007 |
[Second-line chemotherapy with gemcitabine and cisplatin for urothelial cancer previously treated with or resistant to M-VAC therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Urologic Neoplasms; Vinblastine | 2006 |
A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Karnofsky Performance Status; Liver Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Radiotherapy Dosage; Receptor, ErbB-2; Tamoxifen; Time Factors; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2006 |
Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; DNA, Complementary; Electrophoresis, Gel, Two-Dimensional; Female; Fluorouracil; Gels; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Molecular Weight; Neoplasm Proteins; Neoplasm Recurrence, Local; Oligonucleotide Array Sequence Analysis; Proteomics | 2007 |
[A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Hysterectomy; Krukenberg Tumor; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Neoplasms, Multiple Primary; Ovarian Neoplasms; Pancreatectomy; Peritoneal Neoplasms; Pleurisy; Stomach Neoplasms; Survivors | 2006 |
[Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Pelvis; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine | 2006 |
[Breast cancer in young women in the south of Tunisia].
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mammography; Mastectomy; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Analysis; Time Factors; Treatment Outcome; Tunisia | 2006 |
[MTX-CDDP-5-FU double modulation intra aortic chemotherapy for advanced and metastatic gastric cancer--a comparison with an intra venous route].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Stomach Neoplasms | 2006 |
The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; bcl-2 Homologous Antagonist-Killer Protein; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Female; Fluorouracil; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Preoperative Care; Prognosis; Proto-Oncogene Proteins c-bcl-2 | 2007 |
[Results of modified M-VAC chemotherapy for advanced urothelial carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neutropenia; Retrospective Studies; Survival Rate; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 2007 |
Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Humans; Leuprolide; Lymphatic Metastasis; Methotrexate; Patient Selection; Selective Estrogen Receptor Modulators; Tamoxifen | 2007 |
One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Survival Rate; Tamoxifen | 2007 |
[Diagnosis and prognosis study of breast carcinoma with micropapillary component].
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tamoxifen | 2007 |
[Neoadjuvant and adjuvant chemotherapy in patients with advanced penile cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Ifosfamide; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Staging; Penile Neoplasms; Penis; Survival Rate; Taxoids; Treatment Outcome | 2007 |
[Postoperative radiotherapy of the chest wall in patients with male breast cancer].
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Mastectomy, Modified Radical; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radioisotope Teletherapy; Radiotherapy, Adjuvant; Tamoxifen; Thoracic Wall | 2007 |
Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Paclitaxel; Population Surveillance; Practice Patterns, Physicians'; Radiotherapy, Adjuvant; Tamoxifen; Vinblastine; Vincristine | 2007 |
Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Receptor, ErbB-2; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium; Vinblastine | 2007 |
[Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mitomycin; Neoplasm Staging; Postoperative Period; Prognosis; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis; Treatment Outcome | 2007 |
[Neoadjuvant and adjuvant chemotherapy with methotrexate, cisplatin and bleomycin for advanced penile cancer: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Penile Neoplasms; Penis; Treatment Outcome; Urologic Surgical Procedures, Male | 2007 |
Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Doxorubicin; Humans; Lymphatic Metastasis; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2008 |
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Monitoring; Estrogens; Female; Fluorouracil; Follow-Up Studies; Humans; Japan; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Progesterone; Prognosis; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome | 2009 |
[Treatment of advanced maxillary sinus squamous carcinoma: an analysis of 92 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Maxillary Sinus; Maxillary Sinus Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate; Young Adult | 2008 |
Disseminated melanoma. Biologic behavior and treatment.
Topics: Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Hydrazines; Hydroxyurea; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Melphalan; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Perfusion; Vincristine | 1967 |
Cancer of the penis.
Topics: Bleomycin; Carcinoma, Squamous Cell; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Staging; Penile Neoplasms; Prognosis | 1980 |
The treatment of bilateral ulcerated lymph node metastases from carcinoma of the penis. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Humans; Lymphatic Metastasis; Male; Methotrexate; Penile Neoplasms; Radiotherapy Dosage; Ulcer | 1984 |
Combination chemotherapy for the treatment of metastatic basal cell carcinoma of the scrotum. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Cisplatin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Scrotum | 1984 |
[Adriamycin in the combined chemotherapy of small-cell lung cancer].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Procarbazine; Radiotherapy Dosage; Time Factors; Vincristine | 1983 |
Sequential methotrexate and 5-fluorouracil: improved response rate in metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Colonic Neoplasms; Drug Administration Schedule; Drug Eruptions; Drug Evaluation; Drug Synergism; Female; Fluorouracil; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Rectal Neoplasms | 1984 |
[Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Skin Neoplasms; Time Factors | 1984 |
Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Chlorambucil; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Staging; Prognosis | 1984 |
Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Hysterectomy; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
CMF adjuvant programs at the Milan Cancer Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis | 1984 |
[Initial therapeutic evaluations of 141 patients with carcinoma of the breast under 40 years of age].
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Prognosis; Retrospective Studies | 1984 |
[5 years' experiences with adjuvant chemotherapy in primary breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Staging; Prognosis | 1984 |
Methotrexate and 5-fluorouracil in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate; Neoplasm Staging | 1983 |
[Bone scintigraphy in mastectomized patients with and without chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Radionuclide Imaging; Vincristine | 1983 |
Oral and pharyngeal cancer: combined approach for multimodal therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Iridium; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radioisotopes; Time Factors | 1983 |
Prognostic factors in primary breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1983 |
[Breast neoplasms. Progress by means of adjuvant chemotherapy?].
Topics: Age Factors; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Prognosis | 1980 |
Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Methotrexate; Middle Aged; Prognosis | 1983 |
[Radiation and combination treatment of breast cancer metastases to the lungs].
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Time Factors | 1983 |
Adjuvant chemotherapy for stage D1 adenocarcinoma of prostate.
Topics: Adenocarcinoma; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Patient Compliance; Prognosis; Prostatic Neoplasms; Stomatitis; Time Factors | 1983 |
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Random Allocation; Soft Tissue Neoplasms; Thoracic Neoplasms; Time Factors | 1981 |
[Combination of three therapy methods (operation-radiotherapy-chemotherapy) in case of mammary carcinoma with lymph node metastases].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Prednisone; Radiotherapy Dosage | 1982 |
[Value of radiotherapy of cancer of the oral part of the tongue].
Topics: Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth; Radium; Time Factors; Tongue Neoplasms | 1982 |
[Ancillary chemotherapy with trofosfamid, methotrexate and fluoro-uracil in cancer of the breast (author's transl)].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1981 |
A study over a 5-year period of adjuvant chemotherapy after mastectomy for breast cancer.
Topics: Breast Neoplasms; Chlorambucil; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Postoperative Care; Time Factors | 1981 |
[Electron teletherapy and drug therapy of malignant tumors of the maxillofacial area].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Electrons; Facial Neoplasms; Female; Follow-Up Studies; Humans; Jaw Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Particle Accelerators; Radiotherapy Dosage; Vincristine | 1981 |
[Results of, and indications for adjuvant chemotherapy in breast cancer].
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Risk; Vincristine | 1981 |
[Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prognosis; Vincristine | 1981 |
Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancer.
Topics: Antineoplastic Agents; Blood Cell Count; Breast Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukocyte Count; Lymphatic Metastasis; Mastectomy; Melphalan; Methotrexate; Platelet Count | 1981 |
Adjuvant therapy for stage II, estrogen receptor negative breast cancer.
Topics: Actuarial Analysis; Antineoplastic Agents; Axilla; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Receptors, Estrogen; Recurrence | 1981 |
Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Vincristine | 1980 |
[Adjuvant chemotherapy in breast neoplasms. Clinical and immunologic results].
Topics: Adult; Aged; Breast Neoplasms; Concanavalin A; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Lymphocyte Activation; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1980 |
[Drug pathomorphosis of breast cancer (proceedings)].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Prednisolone; Vincristine | 1980 |
Treatment of clinically fixed lymph node metastases from carcinoma of the penis by chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Humans; Inguinal Canal; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Penile Neoplasms | 1993 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluorouracil; Forecasting; Humans; In Vitro Techniques; Lymphatic Metastasis; Melanoma; Methotrexate; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction; Retrospective Studies; Skin Neoplasms; Tumor Cells, Cultured; Vindesine | 1994 |
[Lung residuals following chemotherapy in patients with stage III nonseminomatous testicular cancer. Report of 4 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Peplomycin; Testicular Neoplasms; Thoracotomy; Vincristine | 1994 |
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Keratins; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Analysis; Tamoxifen; Time Factors | 1994 |
[Combination chemotherapy with POMB/ACE (cisplatin, vincristine, methotrexate, bleomycin, actinomycin D, cyclophosphamide, etoposide) in advanced non-seminomatous testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Remission Induction; Teratoma; Testicular Neoplasms; Vincristine | 1995 |
[Advanced gastric carcinoma with extensive lymph node metastases successfully treated by sequential methotrexate/5-fluorouracil therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Remission Induction; Stomach Neoplasms | 1995 |
[New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Neoplasms, Multiple Primary; Salvage Therapy; Testicular Neoplasms | 1993 |
Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Longitudinal Studies; Lymphatic Metastasis; Lymphocyte Activation; Lymphocytes; Menopause; Methotrexate; Middle Aged; Neoplasm Staging; Phytohemagglutinins; Predictive Value of Tests; Prognosis; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1995 |
Successful treatment of metastatic small cell carcinoma of the bladder with methotrexate, vinblastine, doxorubicin and cisplatin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1995 |
[Adriamycin/cyclophosphamide: current standard in adjuvant therapy for breast carcinoma?].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Heart; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged | 1994 |
Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Preoperative Care | 1994 |
Selective delivery of a greater amount of methotrexate to regional lymph nodes using a new dosage formulation, methotrexate adsorbed on activated carbon particles, in rats.
Topics: Adsorption; Animals; Carbon; Chromatography, High Pressure Liquid; Kidney; Liver; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Particle Size; Rats; Spectrophotometry, Ultraviolet; Spleen; Suspensions; Thermodynamics; Tissue Distribution | 1994 |
[The tumor pathomorphosis and status of the regional lymph nodes after the preoperative polychemotherapy of patients with vulvar cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Preoperative Care; Prospidium; Vulvar Neoplasms | 1993 |
[Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Retrospective Studies; Time Factors | 1994 |
Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101).
Topics: Animals; Carcinoma; Cell Division; Cell Line; Chromosome Aberrations; Doxorubicin; Epithelium; Female; Fibroblasts; Humans; Immunohistochemistry; Karyotyping; Lymphatic Metastasis; Methotrexate; Mice; Mice, Inbred CBA; Middle Aged; Neoplasm Transplantation; Ploidies; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tumor Cells, Cultured | 1993 |
Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cause of Death; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Preoperative Care; Pulmonary Embolism; Retrospective Studies; Salvage Therapy; Survival Rate; Ureteral Obstruction; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prednisone; Prognosis; Vincristine | 1994 |
[A case of nonresectable gastric cancer treated by sequential methotrexate and 5-fluorouracil].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Stomach Neoplasms | 1994 |
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cathepsin D; Chemotherapy, Adjuvant; Cyclophosphamide; Estrogens; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prognosis; Proteins; Radioimmunoassay; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Analysis; Tamoxifen; Time Factors; Trefoil Factor-1; Tumor Suppressor Proteins | 1993 |
[Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Peritonitis; Prognosis; Stomach Neoplasms; Survival Rate | 1993 |
Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Time Factors; Transplantation, Autologous; Vincristine | 1993 |
[Quandrantectomy in the conservative treatment of breast carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Italy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Radiotherapy Dosage; Tamoxifen | 1993 |
Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Remission Induction; Risk Factors; Survival Rate; Treatment Failure; Vincristine | 1995 |
Cyclophosphamide, methotrexate, and fluorouracil: still the gold standard?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate | 1996 |
[The efficacy of neoadjuvant chemotherapy and morphological classification of invasive bladder cancer according to chemoresponse].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Methotrexate bound to carbon particles used for treating cancers with lymph node metastases in animal experiments and a clinical pilot study.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Carbon; Digestive System Neoplasms; Dosage Forms; Humans; Leukemia P388; Lymphatic Metastasis; Male; Methotrexate; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Pilot Projects; Rats; Rats, Inbred Strains | 1996 |
Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity--evaluation of late morbidity and a watch policy for the clinically negative neck.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Morbidity; Mouth Neoplasms; Neck; Neoplasms, Second Primary; Osteoradionecrosis; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors | 1996 |
A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma, Signet Ring Cell; Disseminated Intravascular Coagulation; Fluorouracil; Gastrectomy; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Radionuclide Imaging; Stomach Neoplasms | 1996 |
Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate/5-fluorouracil sequential therapy: report of a case.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Humans; Intestinal Neoplasms; Lymphatic Metastasis; Methotrexate | 1997 |
Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitoxantrone; Prognosis; Receptor, ErbB-2; Retrospective Studies; Survival Analysis | 1997 |
Endoscopic local injection of a new drug delivery formulation, anticancer drug bound to carbon particles, for digestive cancers: pilot study.
Topics: Adenocarcinoma; Adsorption; Aged; Aged, 80 and over; Antineoplastic Agents; Carbon; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Humans; Injections, Intralesional; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Peplomycin; Pilot Projects; Stomach Neoplasms; Survival Rate | 1997 |
[Combined breast-preserving surgery, chemotherapy and radiotherapy in the treatment of breast carcinoma. Effect of the interval between surgery and the beginning of radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiotherapy Dosage; Retrospective Studies; Time Factors | 1997 |
The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasms, Multiple Primary; Prognosis; Radiotherapy, High-Energy; Retrospective Studies; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
[A case of papillary adenocarcinoma of the stomach with liver metastases and carcinomatous peritonitis treated effectively by methotrexate/5-fluorouracil sequential chemotherapy].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Peritonitis; Stomach Neoplasms | 1997 |
[A case of scrotal cancer with inguinal lymph node metastasis treated by multidisciplinary modalities including chemotherapy with methotrexate, bleomycin and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Genital Neoplasms, Male; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Scrotum | 1997 |
Feasibility of adjuvant chemotherapy for breast cancer patients.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Constipation; Cyclophosphamide; Cystitis; Doxorubicin; Drug Administration Schedule; Exanthema; Feasibility Studies; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Pyrimidines | 1997 |
Adjuvant cyclophosphamide, methotrexate and fluorouracil for node-positive breast cancer: a lifetime cost-utility analysis based on a modified Q-TWIST method.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate | 1997 |
Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate | 1998 |
[Successful chemotherapy based on in vitro chemosensitivity testing in a case of recurrent thymic carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Adenosquamous; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Thymus Neoplasms; Tumor Cells, Cultured | 1998 |
High incidence of brain metastases in patients treated with an M-VAC regimen for advanced bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Incidence; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prognosis; Radiography; Retrospective Studies; Severity of Illness Index; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1998 |
[Use of adjuvant therapy in patients with metastasis of melanoma to regional lymph nodes].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Injections, Intralymphatic; Interferon Type I; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Methotrexate; Middle Aged; Preoperative Care; Prospidium; Recombinant Proteins; Skin Neoplasms; Time Factors | 1998 |
A pilot study of fiberscopy-guided local injection of anti-cancer drugs bound to carbon particles for control of rectal cancer.
Topics: Aged; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carbon; Colonoscopy; Drug Carriers; Female; Fiber Optic Technology; Humans; Lymphatic Metastasis; Male; Methotrexate; Mice; Mitomycins; Pilot Projects; Rectal Neoplasms | 1998 |
[Chemotherapy repeated injection via pelvic retroperitoneal cannulation].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Dogs; Endometrial Neoplasms; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Ovarian Neoplasms; Pelvis; Random Allocation; Retroperitoneal Space; Thiotepa | 1997 |
[A case of renal pelvic cancer with recurrence of liver metastasis showing partial response by injection of methotrexate and intraarterial infusion of cisplatin and pirarubicin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Injections, Intramuscular; Kidney Neoplasms; Kidney Pelvis; Leucovorin; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate | 1998 |
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Predictive Value of Tests; Prednisone; Prognosis; Receptor, ErbB-2; Treatment Outcome; Vincristine | 1998 |
[Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms; Survival Analysis | 1998 |
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Genes, bcl-2; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Tamoxifen; Time Factors | 1995 |
Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design | 1998 |
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Premenopause; Retrospective Studies | 1998 |
[Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Metaplastic breast cancer: prognosis and response to systemic therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Metaplasia; Methotrexate; Middle Aged; Neoplasms, Complex and Mixed; Palliative Care; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Severity of Illness Index; Survival Rate; Tamoxifen; Treatment Outcome | 1999 |
Estradiol receptor and prognostic parameters of human breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptors, Estradiol; Tamoxifen | 1999 |
[The effect of the parameters of the therapeutic protocol on the efficacy of the adjuvant chemotherapy of breast cancer].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Staging; Postoperative Care; Retrospective Studies; Thiotepa | 1999 |
[A case of adriamycin and methotrexate-resistant recurrent breast cancer treated with doxifluridine and mitomycin C].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local | 1999 |
Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; DNA, Neoplasm; Female; Genes, Tumor Suppressor; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitoxantrone; Neoadjuvant Therapy; Ploidies; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome | 1999 |
Intra-arterial infusion chemotherapy for penile carcinoma with deep inguinal lymph node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Penile Neoplasms | 1999 |
MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Anuria; Cisplatin; Doxorubicin; Humans; Kidney Transplantation; Lymphatic Metastasis; Male; Methotrexate; Recurrence; Urinary Bladder Neoplasms; Vinblastine | 2000 |
Baroreflex failure following radiation therapy for nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Baroreflex; Blood Pressure; Combined Modality Therapy; Cyclophosphamide; Fatigue; Head and Neck Neoplasms; Heart Rate; Humans; Hypotension, Orthostatic; Lymphatic Metastasis; Male; Methotrexate; Nasopharyngeal Neoplasms; Pain; Posture; Radiotherapy; Remission Induction; Valsalva Maneuver; Vincristine | 1999 |
Chemosensitivity of advanced larynx carcinoma cells in vitro and significance of multidrug resistance markers in these tumors.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Cell Survival; Cisplatin; Drug Resistance, Multiple; Fluorouracil; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplasm Metastasis; Neoplasm Staging; Protein Kinase C; Tumor Cells, Cultured | 1998 |
Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prospective Studies | 2000 |
Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cause of Death; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Treatment Failure; Treatment Outcome | 2000 |
[Cox proportion hazard model multivariate analysis of prognosis of 1,484 axillary node-negative breast cancer patients].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Radiotherapy, Adjuvant | 1997 |
Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2000 |
Two patients with N3 bladder cancer successfully treated by internal iliac arterial infusion chemotherapy and irradiation: case reports.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Humans; Iliac Artery; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Staging; Urinary Bladder Neoplasms | 2001 |
Bladder preservation by internal iliac arterial infusion chemotherapy and irradiation in T3 bladder carcinoma patients over the age of 70 years.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Health Services for the Aged; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Methotrexate; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms | 2000 |
[Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome | 2001 |
[Pharmacokinetics of "subselective" arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Catheters, Indwelling; Drug Administration Schedule; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Stomach Neoplasms | 2001 |
Chemoradiation for metastatic SCCA: role of comorbidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Comorbidity; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Methotrexate; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Severity of Illness Index; Survival Analysis | 2001 |
P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Differentiation; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Disease-Free Survival; Female; Flow Cytometry; Fluorouracil; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Tumor Suppressor Protein p53 | 2001 |
Progesterone receptor status of breast cancer metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Time Factors | 2002 |
[Chemotherapy-associated myelosuppression in gynecological oncology].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Data Interpretation, Statistical; Etoposide; Female; Fluorouracil; Hematopoiesis; Humans; Leukopoiesis; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Ovarian Neoplasms; Platelet Count; Radioisotope Teletherapy; Radiotherapy Dosage | 2001 |
[Prognostic factors in lymph node negative breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Multicenter Studies as Topic; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Serine Proteinase Inhibitors; Time Factors; Urokinase-Type Plasminogen Activator | 2002 |
[Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].
Topics: Administration, Oral; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Meta-Analysis as Topic; Methotrexate; Randomized Controlled Trials as Topic; Tamoxifen; Time Factors | 2002 |
[A case of gastric cancer with paraaortic lymph node metastasis responding to preoperative chemotherapy and surviving 4 years and 4 months after total gastrectomy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Stomach Neoplasms; Survivors; Tegafur; Uracil | 2002 |
[Penile metastasis from bladder cancer. A case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Cystectomy; Doxorubicin; Fatal Outcome; Hematuria; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Penile Neoplasms; Prostatectomy; Urinary Bladder Neoplasms; Urinary Diversion; Vinblastine | 2002 |
Esophageal carcinoma. The value of staging in long-term survival.
Topics: Administration, Oral; Cyclophosphamide; Esophageal Neoplasms; Esophagus; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Metastasis; Palliative Care; Prednisone; Vincristine | 1975 |
Ovarian function in patients receiving adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Middle Aged; Ovary; Vincristine | 1977 |
[Chemotherapy of breast cancer].
Topics: Adenocarcinoma, Scirrhous; Breast Neoplasms; Calcinosis; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged | 1976 |
Mastectomy as an adjunct to combination chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Injections, Intravenous; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Prednisone; Vincristine | 1978 |
Oat cell carcinoma of the larynx: response to combined modality therapy.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Laryngeal Neoplasms; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Neck; Radiotherapy Dosage; Remission, Spontaneous | 1978 |
Multidisciplinary treatment for childhood sarcoma.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Lymphatic Metastasis; Male; Methods; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1977 |
Chemotherapy of metastatic carcinoma of the breast. A 4-drug regimen.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Remission, Spontaneous; Vincristine | 1977 |
United States trials of adjuvant therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Melphalan; Menopause; Methotrexate; Thiotepa | 1977 |
[Carminomycin in drug combination in breast cancer and soft tissue sarcomas].
Topics: Aged; Altretamine; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms | 1977 |
5-drug adjuvant chemotherapy for breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1979 |
Adjuvant chemotherapy of breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1979 |
Differential distribution of antitumor agents in primary and secondary tumors.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma 256, Walker; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Hydroxyurea; Lung Neoplasms; Lymphatic Metastasis; Male; Mercaptopurine; Methotrexate; Methylnitrosourea; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Sarcoma, Experimental | 1977 |
[Short-term incubation in vitro with precursors of nucleic acids on human primary tumors and metastases of carcinoma of the breast (author's transl)].
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Deoxyuridine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Female; Humans; Lymphatic Metastasis; Methotrexate; Thymidine; Uridine | 1978 |
[Surgical and radiotherapeutic possibilities of treatment of mouth neoplasms].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Diagnostic Errors; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Papilloma; Tongue Neoplasms | 1978 |
Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment.
Topics: Adrenalectomy; Breast Neoplasms; Castration; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Receptors, Estrogen; Remission, Spontaneous | 1978 |
[Combined irradiation and chemotherapy as postoperative treatment of breast cancer].
Topics: Aged; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate | 1978 |
[Treatment of malpighian epitheliomas of the floor of the mouth with gingival involvement].
Topics: Bone Transplantation; Cervical Plexus; Drug Therapy, Combination; Gingival Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Mandible; Mandibular Prosthesis; Masticatory Muscles; Methotrexate; Mouth Floor; Mouth Mucosa; Mouth Neoplasms; Skin Transplantation; Surgery, Plastic; Transplantation, Autologous | 1976 |
The combined surgical and chemotherapeutic approach to non-seminomatous cancer of the testicle.
Topics: Chlorambucil; Dactinomycin; Drug Therapy, Combination; Dysgerminoma; Humans; Ifosfamide; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Postoperative Complications; Prognosis; Retroperitoneal Space; Teratoma; Testicular Neoplasms | 1977 |
Adjuvant combination chemotherapy with CMF in primary mammary carcinoma.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged | 1977 |
Therapy of primary breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Postoperative Care; Prednisone; Vincristine | 1977 |
[Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Topics: Antigen-Antibody Reactions; BCG Vaccine; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Lectins; Lymphatic Metastasis; Lymphocyte Activation; Lymphocytes; Melanoma; Methotrexate; Recurrence; Remission, Spontaneous; Rosette Formation; Skin Neoplasms; Skin Tests; Tuberculin Test | 1977 |
Perfusion therapy for extremity melanoma.
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Extremities; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Melphalan; Methotrexate; Middle Aged | 1976 |
The role of chemotherapy in the treatment of breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Methotrexate; Prognosis; Time Factors | 1976 |
Multidisciplinary treatment for macrometastatic osteogenic sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Doxorubicin; Female; Humans; Leucovorin; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Radiotherapy Dosage; Vincristine | 1976 |
An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Peritoneal Neoplasms; Pleural Neoplasms; Skin Neoplasms | 1975 |
Combination chemotherapy as an adjuvant treatment in operable breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recurrence; Time Factors | 1976 |
Editorial: Major advance in breast-cancer therapy.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Melphalan; Methotrexate; Neoplasm Metastasis; Prednisone; Time Factors; Vincristine | 1976 |
[Treatment of cancer metastases in the lymph nodes of the neck in undiagnosed primary tumor].
Topics: Adult; Aged; Evaluation Studies as Topic; Female; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Maxillary Neoplasms; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Pharyngeal Neoplasms; Radiotherapy Dosage; Retroperitoneal Neoplasms; Stomach Neoplasms | 1976 |
Chemosensitivity of head and neck cancer with the rapid thymidine incorporation assay and its clinical application.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Child; Cisplatin; Colonic Neoplasms; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycins; Peplomycin; Remission Induction; Stomach Neoplasms; Thymidine; Tritium; Tumor Cells, Cultured | 1992 |
Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Mitomycin; Pleural Neoplasms; Prednisone; Prognosis; Remission Induction; Risk Factors; Sex Factors; Survival Rate; Triazines; Vincristine; Weight Loss | 1992 |
Adjuvant chemotherapy in high-risk breast cancer patients with ten or more positive lymph nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate; Middle Aged; Vinblastine | 1992 |
Comparison of partial and modified radical mastectomy in the community setting--"10 years later".
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate | 1992 |
[High-dose adjuvant chemotherapy with peripheral blood stem cell transplantation for breast cancer with poor prognosis--a pilot study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphatic Metastasis; Methotrexate; Pilot Projects; Prognosis; Vincristine | 1992 |
Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Proportional Hazards Models; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Vincristine | 1992 |
Surgery for local recurrences following deficient radical mastectomy for breast cancer: a selected series of 39 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Radical; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Reoperation | 1992 |
[Cancer chemotherapy for lymph nodal metastases using activated carbon particles adsorbing methotrexate].
Topics: Animals; Carbon; Injections, Intralesional; Leukemia P388; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Mice; Mice, Inbred DBA | 1992 |
[Chemotherapy and thymostimulin in the treatment of advanced-stage breast neoplasms].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Immunoglobulins; Lymphatic Metastasis; Lymphocyte Activation; Lymphocyte Subsets; Methotrexate; Middle Aged; Neoplasm Metastasis; Thymus Extracts | 1992 |
Intravenous or oral adjuvant CMF for node-positive breast cancer.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Simple; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; New South Wales; Prognosis; Survival Analysis; Survival Rate | 1992 |
Comparison of long-term survival of 1986 consecutive patients with breast cancer treated at the National Cancer Institute of Milano, Italy (1971 to 1972 and 1977 to 1978).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Italy; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Survival Rate | 1991 |
Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Uterine Cervical Neoplasms | 1991 |
Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 1991 |
Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Teratoma; Testicular Neoplasms; Vincristine | 1991 |
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1991 |
Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Genital Neoplasms, Male; Humans; Lymphatic Metastasis; Male; Methotrexate; Perineum; Prostatic Neoplasms; Remission Induction; Scrotum; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed | 1991 |
Childhood Ki-1 lymphoma: presentation as a buttock mass.
Topics: Aneuploidy; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Buttocks; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Humans; Ki-1 Antigen; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Remission Induction; Soft Tissue Neoplasms; T-Lymphocytes, Helper-Inducer; Vincristine | 1991 |
Two simple indexes used to evaluate the impact of therapy on the quality of life of patients receiving primary chemotherapy for operable breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Discriminant Analysis; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitoxantrone; Quality of Life; Reproducibility of Results; Surveys and Questionnaires | 1991 |
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthetics; Female; Fluorouracil; Fluoxymesterone; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prednisone; Radiotherapy; Survival Rate; Thiotepa; Vinblastine; Vincristine | 1991 |
[Adjuvant chemotherapy in premenopausal women].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Quality of Life | 1991 |
[Results of treatment following breast-saving therapy: analysis of intramammary recurrence].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Survival Rate | 1990 |
Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment.
Topics: Adult; Aged; Breast Neoplasms; Cause of Death; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Combined Modality Therapy; Female; Glucose; Humans; Injections, Intraventricular; Lung Neoplasms; Lymphatic Metastasis; Meningeal Neoplasms; Meningitis; Methotrexate; Middle Aged; Receptors, Estrogen; Staphylococcal Infections; Survival Rate; Tomography, X-Ray Computed | 1991 |
Preoperative multimodal therapy for locally advanced non-inflammatory breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Radical; Mastectomy, Simple; Menopause; Methotrexate; Preoperative Care; Survival Rate | 1991 |
[Neoadjuvant chemotherapy of locally advanced tumors of the bladder: preliminary experience].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Urinary Bladder Neoplasms; Vinblastine | 1990 |
Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogens, Conjugated (USP); Female; Fluorouracil; Hospitalization; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Necrosis; Postoperative Complications; Retrospective Studies; Skin; Surgical Flaps; Tamoxifen; Time Factors | 1990 |
Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Microscopy, Electron; Middle Aged; Prostatectomy; Urinary Bladder Neoplasms; Vinblastine | 1990 |
[The prevention of skin melanoma metastases to the regional lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Injections, Intralymphatic; Lymphatic Metastasis; Melanoma; Methotrexate; Postoperative Care; Prospidium; Remission Induction; Skin Neoplasms | 1990 |
Acute non lymphoid leukemia following CMF treatment as adjuvant therapy in positive node breast cancer. Case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Female; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Lymphatic Metastasis; Methotrexate | 1990 |
[Adjuvant chemotherapy of breast cancer with the CMFV protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Vincristine | 1990 |
Primary transitional cell carcinoma of prostate: case with lymph node metastasis eradicated by neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Vinblastine | 1990 |
Adjuvant chemotherapy and scar irradiation in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Prednisone; Prospective Studies; Recurrence; Survival Rate | 1990 |
[Drug therapy of pulmonary metastases of breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Vincristine | 1990 |
[Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
Topics: Adult; Aged; Alopecia; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Doxorubicin; Drug Evaluation; Female; Humans; Leukopenia; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prognosis; Urinary Bladder Neoplasms; Vinblastine; Vomiting | 1990 |
[Cases of the regression of advanced bladder tumors (T2-T4) after the use of chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1990 |
[Multitherapy of advanced esophageal carcinoma with special reference to pre- and post-operative administration of cis-platinum].
Topics: Aged; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagoscopy; Esophagus; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Postoperative Care; Preoperative Care; Radiography | 1985 |
[A neo-adjuvant chemotherapy for carcinomas of the hypopharynx and cervical esophagus].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Peplomycin; Pharyngeal Neoplasms | 1985 |
Multicentric reticulohistiocytosis and cancer: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclophosphamide; Female; Fluorouracil; Histiocytes; Humans; Lymphatic Diseases; Lymphatic Metastasis; Methotrexate; Middle Aged; Paraneoplastic Syndromes; Prednisone; Recurrence; Skin Diseases; Staining and Labeling | 1985 |
The impact of combined therapeutic modalities in head, neck, and esophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Methotrexate; Prognosis; Radiotherapy Dosage; Vindesine | 1985 |
[Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Pharyngeal Neoplasms | 1986 |
Treatment of advanced stage mycosis fungoides with bleomycin, doxorubicin, and methotrexate with topical nitrogen mustard (BAM-M).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Liver Injury; Doxorubicin; Female; Humans; Lymphatic Metastasis; Male; Mechlorethamine; Methotrexate; Middle Aged; Mycosis Fungoides; Neutropenia; Skin Diseases; Skin Neoplasms; Splenectomy | 1986 |
The prognostic influence of induction chemotherapy on advanced head and neck carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prognosis | 1986 |
Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Necrosis; Osteosarcoma; Postoperative Care; Preoperative Care; Vincristine | 1987 |
[Chemotherapy and partial surgery in epithelioma of the pharyngo-larynx].
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Methotrexate; Pharyngeal Neoplasms | 1988 |
[Tumor and lymph node response to chemotherapy. Prognosis in cancer of the pyriform sinus and the lateral laryngeal margin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Methotrexate; Pharyngeal Neoplasms; Prognosis; Vincristine | 1988 |
Contemporary chemotherapy and radiotherapy for inguinal metastases of carcinoma of the penis: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Lymphatic Metastasis; Male; Methotrexate; Penile Neoplasms | 1988 |
Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Penile Neoplasms; Pilot Projects; Vincristine | 1988 |
Neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Humans; Italy; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Uterine Cervical Neoplasms | 1989 |
Stromal reaction of carcinomas after cytostatic therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Carcinoma, Squamous Cell; Female; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth; Mouth Neoplasms; Preoperative Care; Vincristine | 1987 |
[Secondary metastasis after excision of oral squamous cancer without local recurrence].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth; Mouth Neoplasms; Neck Dissection; Neoplasm Invasiveness; Picibanil; Postoperative Period; Tongue Neoplasms | 1989 |
Tumor lysis syndrome in nonhematopoietic neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cisplatin; Dysgerminoma; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Testicular Neoplasms; Tumor Lysis Syndrome; Vinblastine | 1989 |
Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Staging; Prognosis; Vincristine | 1989 |
[Two cases of gastrointestinal cancers with major responses to sequential methotrexate 5-FU plus 5'-DFUR].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colonic Neoplasms; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms | 1989 |
[Small-cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Pneumonectomy; Radiotherapy Dosage; Remission Induction | 1989 |
[Tactics in treating patients with small cell cancer of the lung with superior vena cava obstruction syndrome].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Superior Vena Cava Syndrome | 1989 |
Advanced prostatic carcinoma: pulmonary manifestations.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Melphalan; Methotrexate; Middle Aged; Pleural Effusion; Prednisone; Prostatic Neoplasms; Radiography; Retrospective Studies; Vincristine | 1985 |
[A nontraditional variant for the irradiation of locally disseminated forms of lymphogranulomatosis].
Topics: Adolescent; Adult; Combined Modality Therapy; Drug Therapy, Combination; Folic Acid; Hodgkin Disease; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Radiotherapy Dosage; Remission Induction | 1989 |
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Prospective Studies | 1989 |
The role of chemotherapy for node negative breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Methotrexate; Prednisone | 1989 |
[Chemoradiation treatment of the superior vena cava compression syndrome in small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Methylnitrosourea; Middle Aged; Radiotherapy Dosage; Remission Induction; Superior Vena Cava Syndrome; Time Factors | 1988 |
Breast cancer after treatment for osteosarcoma.
Topics: Adenocarcinoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Femoral Neoplasms; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Osteosarcoma; Risk | 1986 |
Two cases with objective complete response to neo-adjuvant chemotherapy of breast carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate | 1986 |
Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prednisone; Radiotherapy, High-Energy; Retrospective Studies; Risk Factors | 1988 |
[Inflammatory breast carcinoma--possibilities and results of surgical treatment and adjuvant chemotherapy, especially when done preoperatively].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Preoperative Care; Tegafur; Time Factors | 1988 |
Comments on primary and adjuvant treatments of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Methotrexate; Prognosis; Recurrence | 1988 |
Continuous cisplatin infusion in combination with vincristine and high-dose methotrexate for advanced osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Humans; Infusions, Intravenous; Lymphatic Metastasis; Methotrexate; Osteosarcoma; Time Factors; Vincristine | 1987 |
Changing aspects in the treatment of squamous cell carcinoma of the oral tongue.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neck Dissection; Postoperative Care; Prognosis; Radiotherapy Dosage; Tongue Neoplasms | 1987 |
[Rational combinations of hormonal and cytostatic agents in disseminated forms of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1987 |
Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Staging; Postoperative Care; Preoperative Care; Tamoxifen; Time Factors | 1987 |
[Chemotherapy of recurrent squamous cell carcinomas in the ENT area with cisplatin/adriamycin (DDP/ADM) and methotrexate/5-fluorouracil (MTX/5-Flu): a retrospective comparison of 2 protocols].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Retrospective Studies | 1986 |
[Compliance in adjuvant chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Patient Compliance; Tamoxifen | 1986 |
Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Ovariectomy; Retrospective Studies; Tamoxifen | 1986 |
[Adjuvant therapy of breast cancer. 1: Cytostatic therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate | 1986 |
[4-component chemotherapy and radiation therapy of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Radiotherapy Dosage; Time Factors | 1986 |
A case for preoperative chemotherapy in advanced urothelial cancer of the upper urinary tract.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Humans; Kidney Neoplasms; Kidney Pelvis; Lymphatic Metastasis; Male; Methotrexate; Premedication | 1986 |
Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Receptors, Estrogen; Vincristine | 1985 |
Combined cryosurgical, chemotherapeutic, and radiotherapeutic management of T1-4N0M0 oral cavity cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Combined Modality Therapy; Cryosurgery; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radioisotope Teletherapy | 1985 |
[Reduced-dose adjuvant CMF-chemotherapy combined with postoperative irradiation in breast cancer with lymphatic metastases. A prospective study of 45 patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cesium Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prognosis; Prospective Studies | 1985 |
[Radio-chemotherapy integration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate | 1985 |
Surgical treatment of carcinoma of the breast. V. Changes in patient population and therapeutic modalities at a metropolitan hospital (1971-1980).
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; California; Cyclophosphamide; Ethnicity; Female; Fluorouracil; Hispanic or Latino; Hospitals, Urban; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Urban Population | 1985 |
Management of inflammatory carcinoma of the breast. A combined modality approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage | 1985 |
Chemotherapy of invasive carcinoma of the bladder.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 1985 |
[Therapy of recurrent squamous cell cancers in the ENT area with the sequential methotrexate (MTX)/5-fluorouracil (5-Fu) protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Prognosis | 1985 |
Maintenance chemotherapy for high-risk patients. A preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Prospective Studies; Risk; Sex Ratio | 1985 |
Long-term survival of patients with localized diffuse histiocytic lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Humans; Leucovorin; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Radiation Injuries; Vincristine | 1985 |
The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Hysterectomy; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Reoperation | 1985 |
[Preoperative cancer chemotherapy for gastric cancer].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Lymphatic Metastasis; Methotrexate; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1985 |
[A case of long-term survival of liver metastasis of breast cancer successfully treated with chemotherapy and endocrine therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Liver; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Methotrexate; Middle Aged; Tamoxifen; Tegafur | 1985 |
[Adjuvant mono- and polychemotherapy in breast cancer (a randomized study)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Staging; Postoperative Care; Radiotherapy; Random Allocation; Thiotepa; Time Factors | 1985 |
Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies | 1985 |
[The significance of reinduction chemotherapy with adriamycin for relapsed non-Hodgkin's lymphoma of Waldeyer's ring].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Lymphoma; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Vincristine | 1985 |
[A case of esophageal carcinoma with liver metastasis treated with cisplatin].
Topics: Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Esophagoscopy; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Tomography, X-Ray Computed | 1985 |
[Transperitoneal lymph node excision and cytostatic postoperative treatment of malignant germinal testicular neoplasms].
Topics: Antineoplastic Agents; Chlorambucil; Dactinomycin; Drug Synergism; Dysgerminoma; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methods; Methotrexate; Postoperative Care; Prognosis; Teratoma; Testicular Neoplasms | 1968 |
Effect of therapy on the serum level of alpha-1 fetoprotein in embryonal cell carcinoma.
Topics: Alpha-Globulins; Child, Preschool; Cyclophosphamide; Dactinomycin; Fetal Proteins; Humans; Immunodiffusion; Immunoelectrophoresis; Lymphatic Metastasis; Male; Mechlorethamine; Methotrexate; Neoplasm Metastasis; Teratoma; Testicular Neoplasms; Testis; Vincristine | 1972 |
Cancer of the tongue.
Topics: Bleomycin; Carcinoma, Squamous Cell; Dental Caries; Electrocoagulation; Fluorides, Topical; Fluorouracil; Glossectomy; Humans; Lymphatic Metastasis; Methotrexate; Neck Dissection; Neoplasm Metastasis; Neoplasm Recurrence, Local; Preoperative Care; Radiotherapy Dosage; Tongue Neoplasms | 1973 |
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy.
Topics: Aged; Antineoplastic Agents; Biopsy, Needle; Bleomycin; Carcinoma, Basal Cell; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Metastasis; Thigh | 1974 |
[Arterial chemotherapy infusions of long duration in the treatment of cancer. Place and limitations of this method].
Topics: Adult; Aged; Female; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Male; Methotrexate; Neoplasms; Palliative Care; Paranasal Sinus Neoplasms | 1965 |
Practical aspects of investigation and treatment of colorectal cancer.
Topics: Colonic Neoplasms; Female; Floxuridine; Fluorouracil; Humans; Infusions, Parenteral; Liver Function Tests; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Metastasis; Proctoscopy; Prognosis; Rectal Neoplasms; Sex Factors | 1972 |
Methotrexate treatment for advanced bladder cancer.
Topics: Aged; Blood Cell Count; Carcinoma, Transitional Cell; Creatinine; Diarrhea; Humans; Kidney Function Tests; Kidney Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Nausea; Neoplasm Metastasis; Urea; Urinary Bladder; Urinary Bladder Neoplasms; Urography; Vomiting | 1974 |
Recurrent head and neck cancer: the results of treatment.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Ear Neoplasms; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lip Neoplasms; Lymphatic Metastasis; Methotrexate; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Pharyngeal Neoplasms; Skin Neoplasms; Surgery, Plastic | 1974 |
Response of a musculo-skeletal tumour to combined radiation therapy. An in vitro/vivo investigation.
Topics: Animals; Cell Line; Glycolysis; Hot Temperature; Lymphatic Metastasis; Methotrexate; Models, Biological; Muscles; Neoplasm Metastasis; Neoplasm Transplantation; Oxygen Consumption; Rabbits; Radiotherapy Dosage; Thymidine; Time Factors; Tritium; Tumor Virus Infections | 1974 |
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radioisotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Cattle; Depression, Chemical; DNA, Neoplasm; Female; Fluorouracil; Humans; In Vitro Techniques; Iodoacetates; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Mice; Neoplasms; Phenylalanine; Succinate Dehydrogenase; Thymidine; Tritium | 1974 |
Arterial infusion and radiation therapy in the treatment of advanced cancer of the nasal cavity and paranasal sinuses.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Carotid Artery, External; Carotid Artery, Internal; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Maxillary Artery; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nose Neoplasms; Paranasal Sinus Neoplasms | 1973 |
Clinical evaluation of patients treated for rhabdomyosarcoma.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Evaluation Studies as Topic; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Postoperative Care; Radiotherapy Dosage; Recurrence; Rhabdomyosarcoma; Thiotepa; Time Factors | 1972 |
[Therapy of the progressive metastasizing breast carcinoma].
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Cyclophosphamide; Female; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Radiography; Remission, Spontaneous; Vinblastine | 1973 |
Hyperthermia (42 degrees C) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic VX2 carcinoma in the rabbit.
Topics: Animals; Body Temperature; Hindlimb; Hyperthermia, Induced; Lymphatic Metastasis; Male; Methotrexate; Mitosis; Neoplasm Metastasis; Neoplasms, Experimental; Rabbits | 1973 |
The clinical and pathologic features of "non-hormonal" adrenocortical tumors. Report of twenty new cases and review of the literature.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; Aged; Angiography; Antineoplastic Agents; Carcinoma; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Lymphography; Male; Methotrexate; Middle Aged; Mitotane; Prednisone; Urography; Vincristine | 1974 |
[Lymphatic route in the diagnosis and treatment of cervical lymphopathies].
Topics: Antineoplastic Agents; Cesium Isotopes; Coloring Agents; Contrast Media; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Methods; Methotrexate | 1971 |
The surgical management of testis tumors.
Topics: Adolescent; Adult; Castration; Child; Child, Preschool; Chlorambucil; Choriocarcinoma; Dactinomycin; Dysgerminoma; Humans; Infant; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methods; Methotrexate; Middle Aged; Teratoma; Testicular Neoplasms | 1971 |
Association of cancer of the breast and acute myelocytic leukemia.
Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Breast Neoplasms; Carcinoma; Female; Fluorouracil; Humans; Leukemia, Myeloid; Lymphatic Metastasis; Mastectomy; Mercaptopurine; Methotrexate; Middle Aged | 1967 |
Management of cancer of the larynx.
Topics: Female; Glottis; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Methotrexate | 1970 |
Combined therapy in buccal mucosal cancers.
Topics: Carcinoma, Squamous Cell; Cheek; Cobalt Isotopes; Humans; Hyperbaric Oxygenation; India; Lymphatic Metastasis; Methotrexate; Mouth Mucosa; Mouth Neoplasms; Neck Dissection; Nicotiana; Plants, Toxic; Radiation-Sensitizing Agents; Radioisotope Teletherapy; Radium | 1971 |
Metastatic basal cell carcinoma.
Topics: Biopsy; Carcinoma, Basal Cell; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Skin Neoplasms | 1969 |